JP6967334B2 - Compositions Containing Polyunsaturated Fatty Acid Esters - Google Patents
Compositions Containing Polyunsaturated Fatty Acid Esters Download PDFInfo
- Publication number
- JP6967334B2 JP6967334B2 JP2015248498A JP2015248498A JP6967334B2 JP 6967334 B2 JP6967334 B2 JP 6967334B2 JP 2015248498 A JP2015248498 A JP 2015248498A JP 2015248498 A JP2015248498 A JP 2015248498A JP 6967334 B2 JP6967334 B2 JP 6967334B2
- Authority
- JP
- Japan
- Prior art keywords
- fatty acid
- acid
- polyunsaturated fatty
- ethyl ester
- less
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims description 125
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 title claims description 35
- 150000002148 esters Chemical class 0.000 title claims description 19
- 125000004494 ethyl ester group Chemical group 0.000 claims description 73
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 51
- 239000001301 oxygen Substances 0.000 claims description 51
- 229910052760 oxygen Inorganic materials 0.000 claims description 51
- 150000002978 peroxides Chemical class 0.000 claims description 41
- 102000002322 Egg Proteins Human genes 0.000 claims description 36
- 108010000912 Egg Proteins Proteins 0.000 claims description 36
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 30
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims description 26
- 239000002253 acid Substances 0.000 claims description 25
- 230000003078 antioxidant effect Effects 0.000 claims description 24
- 239000003963 antioxidant agent Substances 0.000 claims description 21
- 235000006708 antioxidants Nutrition 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims description 20
- 235000014103 egg white Nutrition 0.000 claims description 20
- 210000000969 egg white Anatomy 0.000 claims description 20
- 210000002969 egg yolk Anatomy 0.000 claims description 20
- 235000013345 egg yolk Nutrition 0.000 claims description 19
- 235000020673 eicosapentaenoic acid Nutrition 0.000 claims description 19
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 claims description 18
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 13
- 229930003427 Vitamin E Natural products 0.000 claims description 12
- 235000019165 vitamin E Nutrition 0.000 claims description 12
- 239000011709 vitamin E Substances 0.000 claims description 12
- 229940046009 vitamin E Drugs 0.000 claims description 12
- YUFFSWGQGVEMMI-JLNKQSITSA-N (7Z,10Z,13Z,16Z,19Z)-docosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(O)=O YUFFSWGQGVEMMI-JLNKQSITSA-N 0.000 claims description 11
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 claims description 11
- 235000000072 L-ascorbyl-6-palmitate Nutrition 0.000 claims description 11
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 claims description 11
- 239000003995 emulsifying agent Substances 0.000 claims description 11
- 239000008347 soybean phospholipid Substances 0.000 claims description 11
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims description 8
- 229940090949 docosahexaenoic acid Drugs 0.000 claims description 6
- 235000021294 Docosapentaenoic acid Nutrition 0.000 claims description 5
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims description 5
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 claims description 5
- 229960005135 eicosapentaenoic acid Drugs 0.000 claims description 5
- OPGOLNDOMSBSCW-CLNHMMGSSA-N Fursultiamine hydrochloride Chemical compound Cl.C1CCOC1CSSC(\CCO)=C(/C)N(C=O)CC1=CN=C(C)N=C1N OPGOLNDOMSBSCW-CLNHMMGSSA-N 0.000 claims description 4
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims description 4
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims description 4
- 229960004488 linolenic acid Drugs 0.000 claims description 4
- JIWBIWFOSCKQMA-UHFFFAOYSA-N stearidonic acid Natural products CCC=CCC=CCC=CCC=CCCCCC(O)=O JIWBIWFOSCKQMA-UHFFFAOYSA-N 0.000 claims description 4
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims description 2
- 235000021342 arachidonic acid Nutrition 0.000 claims description 2
- 229940114079 arachidonic acid Drugs 0.000 claims description 2
- 235000020778 linoleic acid Nutrition 0.000 claims description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims description 2
- 238000000034 method Methods 0.000 description 143
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 55
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 43
- 239000003921 oil Substances 0.000 description 42
- 235000019198 oils Nutrition 0.000 description 42
- 235000013305 food Nutrition 0.000 description 39
- 238000005886 esterification reaction Methods 0.000 description 36
- 235000019645 odor Nutrition 0.000 description 33
- 239000003925 fat Substances 0.000 description 32
- 235000019197 fats Nutrition 0.000 description 31
- -1 alcohol ester Chemical class 0.000 description 30
- 235000014113 dietary fatty acids Nutrition 0.000 description 28
- 229930195729 fatty acid Natural products 0.000 description 28
- 239000000194 fatty acid Substances 0.000 description 28
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 24
- 230000003647 oxidation Effects 0.000 description 23
- 238000007254 oxidation reaction Methods 0.000 description 23
- 238000004809 thin layer chromatography Methods 0.000 description 23
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 22
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 22
- 239000003463 adsorbent Substances 0.000 description 20
- 235000021323 fish oil Nutrition 0.000 description 19
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 18
- 150000004665 fatty acids Chemical class 0.000 description 18
- 239000000741 silica gel Substances 0.000 description 18
- 229910002027 silica gel Inorganic materials 0.000 description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- 230000032050 esterification Effects 0.000 description 16
- 238000000199 molecular distillation Methods 0.000 description 16
- 230000008569 process Effects 0.000 description 16
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
- 238000000354 decomposition reaction Methods 0.000 description 15
- 244000294411 Mirabilis expansa Species 0.000 description 14
- 235000015429 Mirabilis expansa Nutrition 0.000 description 14
- 238000006243 chemical reaction Methods 0.000 description 14
- 235000013536 miso Nutrition 0.000 description 14
- 239000004927 clay Substances 0.000 description 13
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 12
- 235000012149 noodles Nutrition 0.000 description 12
- 239000000843 powder Substances 0.000 description 12
- 238000003860 storage Methods 0.000 description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 11
- 238000002156 mixing Methods 0.000 description 11
- 239000000546 pharmaceutical excipient Substances 0.000 description 11
- 239000002994 raw material Substances 0.000 description 11
- 239000000126 substance Substances 0.000 description 11
- 238000011161 development Methods 0.000 description 10
- 238000011156 evaluation Methods 0.000 description 10
- 230000001953 sensory effect Effects 0.000 description 10
- 239000007787 solid Substances 0.000 description 10
- 238000001694 spray drying Methods 0.000 description 10
- 238000004587 chromatography analysis Methods 0.000 description 9
- ITNKVODZACVXDS-YNUSHXQLSA-N ethyl (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoate Chemical compound CCOC(=O)CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC ITNKVODZACVXDS-YNUSHXQLSA-N 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 238000005516 engineering process Methods 0.000 description 8
- 239000000796 flavoring agent Substances 0.000 description 8
- 235000019634 flavors Nutrition 0.000 description 8
- 239000007789 gas Substances 0.000 description 8
- 125000005456 glyceride group Chemical group 0.000 description 8
- 150000002632 lipids Chemical class 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- 238000004821 distillation Methods 0.000 description 7
- 238000001035 drying Methods 0.000 description 7
- 238000000227 grinding Methods 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 229910052757 nitrogen Inorganic materials 0.000 description 7
- 229940012843 omega-3 fatty acid Drugs 0.000 description 7
- 150000003904 phospholipids Chemical class 0.000 description 7
- 235000014347 soups Nutrition 0.000 description 7
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 7
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
- 239000003513 alkali Substances 0.000 description 6
- 239000001569 carbon dioxide Substances 0.000 description 6
- 229910002092 carbon dioxide Inorganic materials 0.000 description 6
- 230000006866 deterioration Effects 0.000 description 6
- 229910001873 dinitrogen Inorganic materials 0.000 description 6
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 6
- 238000001704 evaporation Methods 0.000 description 6
- 230000008020 evaporation Effects 0.000 description 6
- 235000021588 free fatty acids Nutrition 0.000 description 6
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 6
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 239000003377 acid catalyst Substances 0.000 description 5
- 150000001299 aldehydes Chemical class 0.000 description 5
- 238000009835 boiling Methods 0.000 description 5
- 230000005587 bubbling Effects 0.000 description 5
- 239000003054 catalyst Substances 0.000 description 5
- 238000004945 emulsification Methods 0.000 description 5
- 238000006911 enzymatic reaction Methods 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 230000007935 neutral effect Effects 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 5
- 235000012239 silicon dioxide Nutrition 0.000 description 5
- 241000251468 Actinopterygii Species 0.000 description 4
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 4
- 229940123973 Oxygen scavenger Drugs 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 230000004888 barrier function Effects 0.000 description 4
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 4
- 235000013601 eggs Nutrition 0.000 description 4
- 239000012535 impurity Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000000873 masking effect Effects 0.000 description 4
- 239000005022 packaging material Substances 0.000 description 4
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 4
- 229930003799 tocopherol Natural products 0.000 description 4
- 239000011732 tocopherol Substances 0.000 description 4
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 3
- 239000004367 Lipase Substances 0.000 description 3
- 102000004882 Lipase Human genes 0.000 description 3
- 108090001060 Lipase Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 108010073771 Soybean Proteins Proteins 0.000 description 3
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 3
- 235000008429 bread Nutrition 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 235000013365 dairy product Nutrition 0.000 description 3
- 235000013312 flour Nutrition 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 238000009775 high-speed stirring Methods 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 239000011261 inert gas Substances 0.000 description 3
- 235000019421 lipase Nutrition 0.000 description 3
- 235000013622 meat product Nutrition 0.000 description 3
- 239000006014 omega-3 oil Substances 0.000 description 3
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 229910001961 silver nitrate Inorganic materials 0.000 description 3
- 229940001941 soy protein Drugs 0.000 description 3
- 229940083466 soybean lecithin Drugs 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- FKHIFSZMMVMEQY-UHFFFAOYSA-N talc Chemical compound [Mg+2].[O-][Si]([O-])=O FKHIFSZMMVMEQY-UHFFFAOYSA-N 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- 239000010409 thin film Substances 0.000 description 3
- 235000010384 tocopherol Nutrition 0.000 description 3
- 229960001295 tocopherol Drugs 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- 239000008158 vegetable oil Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 2
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 241000269851 Sarda sarda Species 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- WGVKWNUPNGFDFJ-DQCZWYHMSA-N beta-Tocopherol Natural products OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C WGVKWNUPNGFDFJ-DQCZWYHMSA-N 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 150000001728 carbonyl compounds Chemical class 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 210000000991 chicken egg Anatomy 0.000 description 2
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 239000011162 core material Substances 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 238000001640 fractional crystallisation Methods 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000000395 magnesium oxide Substances 0.000 description 2
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 2
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 2
- 239000008268 mayonnaise Substances 0.000 description 2
- 235000010746 mayonnaise Nutrition 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 239000003094 microcapsule Substances 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 239000007764 o/w emulsion Substances 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- BHAAPTBBJKJZER-UHFFFAOYSA-N p-anisidine Chemical compound COC1=CC=C(N)C=C1 BHAAPTBBJKJZER-UHFFFAOYSA-N 0.000 description 2
- 238000011085 pressure filtration Methods 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000007493 shaping process Methods 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 229960000984 tocofersolan Drugs 0.000 description 2
- 235000004835 α-tocopherol Nutrition 0.000 description 2
- 239000002076 α-tocopherol Substances 0.000 description 2
- GZIFEOYASATJEH-VHFRWLAGSA-N δ-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-VHFRWLAGSA-N 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- PBTPTBMYJPCXRQ-MGMRMFRLSA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;hexadecanoic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCCCC(O)=O PBTPTBMYJPCXRQ-MGMRMFRLSA-N 0.000 description 1
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 208000000575 Arteriosclerosis Obliterans Diseases 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 239000001879 Curdlan Substances 0.000 description 1
- 229920002558 Curdlan Polymers 0.000 description 1
- GZIFEOYASATJEH-UHFFFAOYSA-N D-delta tocopherol Natural products OC1=CC(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-UHFFFAOYSA-N 0.000 description 1
- 229920000064 Ethyl eicosapentaenoic acid Polymers 0.000 description 1
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 1
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 208000030831 Peripheral arterial occlusive disease Diseases 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 108060008539 Transglutaminase Proteins 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 238000006701 autoxidation reaction Methods 0.000 description 1
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 239000006103 coloring component Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000001944 continuous distillation Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 235000019316 curdlan Nutrition 0.000 description 1
- 229940078035 curdlan Drugs 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 235000010389 delta-tocopherol Nutrition 0.000 description 1
- 230000001877 deodorizing effect Effects 0.000 description 1
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- SSQPWTVBQMWLSZ-AAQCHOMXSA-N ethyl (5Z,8Z,11Z,14Z,17Z)-icosapentaenoate Chemical compound CCOC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC SSQPWTVBQMWLSZ-AAQCHOMXSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 229940013317 fish oils Drugs 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 235000010382 gamma-tocopherol Nutrition 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000003505 heat denaturation Methods 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- MGJXBDMLVWIYOQ-UHFFFAOYSA-N methylazanide Chemical compound [NH-]C MGJXBDMLVWIYOQ-UHFFFAOYSA-N 0.000 description 1
- 230000007658 neurological function Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 150000003905 phosphatidylinositols Chemical class 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 235000021487 ready-to-eat food Nutrition 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 102000003601 transglutaminase Human genes 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 235000007680 β-tocopherol Nutrition 0.000 description 1
- 239000011590 β-tocopherol Substances 0.000 description 1
- 239000002478 γ-tocopherol Substances 0.000 description 1
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 description 1
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 1
- 239000002446 δ-tocopherol Substances 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Edible Oils And Fats (AREA)
- General Preparation And Processing Of Foods (AREA)
Description
本発明は、高度不飽和脂肪酸の酸化の進行を妨げるおよび/または遅らせることを特徴とする、高度不飽和脂肪酸または高度不飽和脂肪酸エステル含有組成物及び該組成物を含有する食品に関する。例えば、本発明の組成物は、溶存酸素量が1mg/L以下であって、過酸化物価3以下かつ酸価1以下かつアニシジン価5以下であって、かつ、(例えば、吸着剤処理によって)過酸化物を除去したω3系高度不飽和脂肪酸のエチルエステルと、大豆リン脂質及びビタミンE及びアスコルビン酸パルミテートを含む混合物と卵黄の乳化混合物に、更に、卵白を加えて均質化した組成物を噴霧乾燥法により乾燥し、水分含量を5wt%以下に調整した粉末であることを特徴とするω3系高度不飽和脂肪酸エチルエステル含有組成物並びに該組成物を含有する食品に関する。 The present invention relates to polyunsaturated fatty acid or polyunsaturated fatty acid ester-containing compositions and foods containing the compositions, which are characterized by inhibiting and / or delaying the progress of oxidation of polyunsaturated fatty acids. For example, the composition of the present invention has a dissolved oxygen content of 1 mg / L or less, a peroxide value of 3 or less, an acid value of 1 or less and an anicidin value of 5 or less, and (for example, by adsorbent treatment). A mixture containing ethyl ester of ω3 highly unsaturated fatty acid from which peroxide has been removed, soybean phospholipid and vitamin E, and palmitate ascorbic acid and an emulsified mixture of egg yolk are further sprayed with a homogenized composition by adding egg white. The present invention relates to a composition containing an ω3 highly unsaturated fatty acid ethyl ester, which is dried by a drying method and whose water content is adjusted to 5 wt% or less, and a food containing the composition.
魚油、藻類、遺伝子組み換え植物等に含まれるALA、SDA、EPA、DPA、DHA等のω3系高度不飽和脂肪酸又はそのエチルエステルは循環器系疾患改善、脳神経機能の改善、免疫機能の改善だけでなく、酸化ストレス抑制を介する疾病の予防改善など広範な機能を発揮し、更に、癌の増殖抑制にも有効とされるなど用途の拡大が続いている素材である(非特許文献1および2、ならびに、特許文献1)。 Ω3 polyunsaturated fatty acids such as ALA, SDA, EPA, DPA, and DHA contained in fish oil, algae, genetically modified plants, etc. or their ethyl esters can only improve cardiovascular disease, neurological function, and immune function. It is a material that exerts a wide range of functions such as prevention and improvement of diseases through suppression of oxidative stress, and is also effective in suppressing the growth of cancer, and its applications are continuing to expand (Non-Patent Documents 1 and 2, In addition, Patent Document 1).
これらω3系脂肪酸はグリセリド体又は遊離型脂肪酸やエチルエステル体としてそのままで、又は、濃縮精製されて食品素材、健康食品素材、化粧品素材、医薬品素材として上市されている。これらのω3系脂肪酸は一般に、真空精密蒸留法、分子蒸留法、クロマト法、低温溶媒分別結晶法、尿素付加法、硝酸銀錯体形成法、などを適時組み合わせて濃縮されている(特許文献2)。 These ω3 fatty acids are marketed as food materials, health food materials, cosmetic materials, and pharmaceutical materials as they are as glycerides, free fatty acids, or ethyl esters, or after being concentrated and purified. These ω3 fatty acids are generally concentrated by a timely combination of a vacuum precision distillation method, a molecular distillation method, a chromatographic method, a low temperature solvent fractional crystallization method, a urea addition method, a silver nitrate complex forming method, and the like (Patent Document 2).
特に、EPAのエチルエステル体(以下EPAエチル)はスイッチOTCとして閉塞性動脈硬化症、高脂血症等の治療薬として販売が開始され、医薬品グレードEPAエチルの市場拡大が続いている。 In particular, the ethyl ester form of EPA (hereinafter referred to as EPA ethyl) has been launched as a switch OTC as a therapeutic agent for arteriosclerosis obliterans, hyperlipidemia, etc., and the market for pharmaceutical grade EPA ethyl continues to expand.
また、グリセリド体としてそのままで、又はエチルエステル体を濃縮精製した後、市販されているものもある。例えば、魚油を出発原料とする時、該グリセリドに含まれるω3系脂肪酸は低温溶媒分別結晶法により濃縮されたり、リパーゼなど酵素処理により濃縮される場合もあるが、商業規模では該ω3系脂肪酸純度は70%が限界とされている。 In addition, some are commercially available as glycerides as they are or after the ethyl ester is concentrated and purified. For example, when fish oil is used as a starting material, the ω3 fatty acid contained in the glyceride may be concentrated by a low temperature solvent fractional crystallization method or by an enzyme treatment such as lipase, but on a commercial scale, the ω3 fatty acid purity. Is limited to 70%.
ω3系脂肪酸純度が90wt%以上のグリセリドは少なくとも90wt%以上の当該脂肪酸又はその低級アルコールエステルを出発原料とし、グリセリンとのエステルとすることによって合成される。エステル化反応は一般にリパーゼによる可逆反応、又は酸、アルカリによる化学的合成反応によって得ることが出来る。なお、上記90wt%以上の当該脂肪酸又はその低級アルコールエステルは公知の方法によって得ることが出来る(特許文献3、4)。 A glyceride having an ω3 fatty acid purity of 90 wt% or more is synthesized by using the fatty acid having a purity of at least 90 wt% or a lower alcohol ester thereof as a starting material and using it as an ester with glycerin. The esterification reaction can generally be obtained by a reversible reaction with lipase or a chemical synthesis reaction with an acid or an alkali. The fatty acid of 90 wt% or more or a lower alcohol ester thereof can be obtained by a known method (Patent Documents 3 and 4).
すなわち、例えば、ALA、SDA、EPA、DPA、DHA等から選ばれる何れか1種類のω3系高度不飽和脂肪酸を70wt%以上の高純度に精製するためには、当該脂肪酸又はその低級アルコールエステルの形であることが好ましい。また、蒸留設備を用いる場合、設備上及び脂肪酸の沸点等の物性上の特徴から、遊離脂肪酸ではなくその低級アルコールエステルの形での濃縮精製が現実的である。 That is, for example, in order to purify any one of the ω3 polyunsaturated fatty acids selected from ALA, SDA, EPA, DPA, DHA, etc. to a high purity of 70 wt% or more, the fatty acid or its lower alcohol ester is used. It is preferably in the form. Further, when a distillation facility is used, it is practical to concentrate and purify in the form of a lower alcohol ester instead of a free fatty acid because of the physical characteristics such as the facility and the boiling point of the fatty acid.
更に、脂肪酸の低級アルコールエステルの場合、食品、医薬品、化粧品等の分野での利用を想定した場合は、そのエチルエステルが最も望ましい。 Further, in the case of a lower alcohol ester of a fatty acid, the ethyl ester is most desirable when it is assumed to be used in the fields of foods, pharmaceuticals, cosmetics and the like.
しかしながら、これらのω3系高度不飽和脂肪酸のグリセリド体又は遊離型脂肪酸やエチルエステル体は1分子当たり3〜6個の不飽和結合を有するため酸化速度が大きく、また、極微量の過酸化物の生成は十分に不快な魚臭を伴う。掛かる問題解決のため、多くの酸化防止技術、魚臭除去技術、マスキング技術が提案されてきた。 However, since the glycerides of these ω3 polyunsaturated fatty acids or free fatty acids and ethyl esters have 3 to 6 unsaturated bonds per molecule, the oxidation rate is high, and a very small amount of peroxide is used. The production is accompanied by a sufficiently unpleasant fishy odor. Many antioxidant technologies, fish odor removal technologies, and masking technologies have been proposed to solve the problems.
抗酸化剤に関しては、ビタミンE、アスコルビン酸パルミテート、レシチンを併用する方法(特許文献5)、香辛料抽出物を用いる方法(特許文献6、7)多数の特許文献が見られる。ω3系高度不飽和脂肪酸を多く含む魚油に関しては、大豆リン脂質中のホスファチジルコリンやホスファチジルエタノールアミンなどの含窒素リン脂質のビタミンEに対する相乗的な抗酸化作用(非特許文献3)、アスコルビン酸パルミテートの有効性(特許文献2)が知られているが、いずれの方法も酸化の進行を完全に妨げることは出来ていない。 As for antioxidants, a large number of patent documents can be found, including a method in which vitamin E, ascorbic acid palmitate, and lecithin are used in combination (Patent Document 5), and a method in which a spice extract is used (Patent Documents 6 and 7). Regarding fish oil containing a large amount of ω3 highly unsaturated fatty acids, the synergistic antioxidant action of nitrogen-containing phospholipids such as phosphatidylcholine and phosphatidylethanolamine in soybean phospholipids against vitamin E (Non-Patent Document 3), ascorbic acid palmitate. Although its effectiveness (Patent Document 2) is known, neither method can completely prevent the progress of oxidation.
掛かる問題点改善のため、植物油脂に含まれる溶存酸素を低減することによる保存安定性向上を目指す技術が公知となっている。すなわち、油脂へのハイドロキノン添加による溶存酸素の低減化(非特許文献4)、油脂中の酸素を含む溶存気体を二酸化炭素置換することによる風味改善方法(特許文献8)、窒素ガス置換によるマヨネーズなどの水中油型乳化物中の溶存酸素低減化と品質の劣化防止に関する方法(特許文献9)などが公知であり有効性が明らかとなっている。 In order to improve the problems involved, a technique aiming at improving storage stability by reducing dissolved oxygen contained in vegetable oils and fats is known. That is, reduction of dissolved oxygen by adding hydroquinone to fats and oils (Non-Patent Document 4), flavor improvement method by substituting oxygen-containing dissolved gas in fats and oils with carbon dioxide (Patent Document 8), mayonnaise by substituting nitrogen gas, etc. A method for reducing dissolved oxygen in an oil-in-water emulsion and preventing deterioration of quality (Patent Document 9) is known and its effectiveness has been clarified.
上記の溶存酸素を低減させる工程の有無に拘わらず、一般に、高度不飽和脂肪酸含有のグリセリド脂質類とそのエチルエステル類、並びに、ALA、SDA、EPA、DPA、DHA等のω3系高度不飽和脂肪酸のエチルエステルを含む脂質類は例えばそのアルキルラジカル(L・)やペルオキシラジカル(LOO・)などの過酸化物や分解物をアルコールやケトン類、アルデヒド類、酸類などの形で含んでおり、これらは官能評価上及び栄養学上の障害になるだけでなく、例えば連鎖反応の誘発などを介して品質の更なる劣化原因となるため除去することが必要である。従って、過酸化物やその分解物の除去は製品の官能評価や栄養学的価値を向上させるだけでなく、過酸化物価(POV)、酸価(AV)、アニシジン価(AnV)の低減化に有効である。 Regardless of the presence or absence of the above steps for reducing dissolved oxygen, in general, polyunsaturated fatty acid-containing glyceride lipids and their ethyl esters, and ω3 polyunsaturated fatty acids such as ALA, SDA, EPA, DPA, and DHA. Lipids containing the ethyl ester of the above contain, for example, peroxides and decomposition products such as their alkyl radicals (L.) and peroxy radicals (LOO.) In the form of alcohols, ketones, aldehydes, acids and the like. It is necessary to remove the ester because it not only becomes an obstacle in sensory evaluation and nutrition, but also causes further deterioration of quality through, for example, induction of a chain reaction. Therefore, removal of peroxides and their decomposition products not only improves the sensory evaluation and nutritional value of the product, but also reduces the peroxide value (POV), acid value (AV), and anicidin value (AnV). It is valid.
油脂中の過酸化脂質やその分解物の除去は多数公知となっているが、例えば、分子蒸留法(特許文献10)、吸着剤処理法(特許文献2、特許文献11、特許文献12、特許文献13)などが知られており、本発明に於いては何れの方法も利用可能である。実験的にはフロリジル(100/200メッシュ)カラムを用いた過酸化脂質の除去法が知られている(非特許文献5)。 The removal of lipid peroxides and their decomposition products in fats and oils is widely known. For example, a molecular distillation method (Patent Document 10), an adsorbent treatment method (Patent Document 2, Patent Document 11, Patent Document 12, and Patent Document 12) are known. Document 13) and the like are known, and any method can be used in the present invention. Experimentally, a method for removing lipid peroxide using a Florisil (100/200 mesh) column is known (Non-Patent Document 5).
過酸化脂質及びその分解物の検出は、例えば、シリカゲル60PF254TLCプレート(Merk社、0.25mm厚さ)を用いる薄層クロマトグラフィー(TLC)法、ケイ酸カラムクロマトグラフィー法、高速液体クロマトグラフィー(HPLC)法等が知られている(非特許文献5)。また、例えば、シリカゲル薄層クロマトグラフィー(TLC)で中性脂質用展開溶媒(n−ヘキサン/ジエチルエーテル/酢酸=85/15/1)を用いて定性的に検定した時、原点付近に過酸化物の存在しているか否かによって簡易的に検定することも公知である。 Detection of lipid peroxide and its decomposition products is performed, for example, by thin layer chromatography (TLC) method using silica gel 60PF 254 TLC plate (Merk, 0.25 mm thickness), silicic acid column chromatography, high performance liquid chromatography. (HPLC) method and the like are known (Non-Patent Document 5). Further, for example, when qualitatively assayed by silica gel thin layer chromatography (TLC) using a developing solvent for neutral lipids (n-hexane / diethyl ether / acetic acid = 85/15/1), a peroxide near the origin is obtained. It is also known to perform a simple test based on the presence or absence of an object.
高度不飽和脂肪酸含有油脂類からの脱臭方法に関しては水蒸気蒸留法、分子蒸留法、ケイ酸カラムクロマト法など多数の技術が公知であるが、いずれも十分ではない(非特許文献2)。 Many techniques such as steam distillation method, molecular distillation method, and silicic acid column chromatographic method are known as methods for deodorizing polyunsaturated fatty acid-containing fats and oils, but none of them is sufficient (Non-Patent Document 2).
マスキング方法に関しては脂溶性ジンジャーフレーバーを用いる方法(特許文献14)、香辛料抽出物を用いる方法(特許文献6,7)、柑橘系香料やヨーグルト香料を用いる方法(特許文献15)、羅漢果抽出物を用いる方法(特許文献16)などの他多数の技術が公開されており、有効性が認められるものもあるが、マスキングに用いるフレーバーの種類により其々の用途が限定されるという欠点が問題となっている。 Regarding the masking method, a method using a fat-soluble ginger flavor (Patent Document 14), a method using a spice extract (Patent Documents 6 and 7), a method using a citrus flavor or a yogurt flavor (Patent Document 15), and a Rakan fruit extract are used. Many other technologies such as the method to be used (Patent Document 16) have been published, and some of them have been confirmed to be effective, but the drawback is that their uses are limited depending on the type of flavor used for masking. ing.
また、該油脂は常温では液状であるため、通常の工程での他原料との混合の困難、包装、運搬上の困難、酸素との高い接触頻度に伴う酸化に起因する魚臭様の異臭発現などが発生し、食品への用途が限定される。掛かる問題点解決のため、該油脂の粉末化に関する技術が公開されている。 In addition, since the fat and oil is liquid at room temperature, it is difficult to mix it with other raw materials in a normal process, it is difficult to package and transport it, and it develops a fishy odor-like offensive odor due to oxidation due to high contact frequency with oxygen. And so on, and its use in food is limited. In order to solve the problems, the technology related to powdering the fats and oils is open to the public.
すなわち、DHA含有油脂の酵母菌体内への封入によるマイクロカプセル化(特許文献17)、トランスグルタミナーゼにより硬化されたゼラチンを用いた膜を有するマイクロカプセル(特許文献18)、モノグリセリドを含む乳化物の粉末化(特許文献19)、賦形剤として脱脂大豆を用いる方法(特許文献20),多層構造のマイクロカプセル(特許文献21)など多数の技術が開示されている。 That is, microencapsulation of DHA-containing fats and oils in yeast cells (Patent Document 17), microcapsules having a membrane using gelatin cured by transglutaminase (Patent Document 18), and emulsion powder containing monoglyceride. Many techniques are disclosed, such as chemical conversion (Patent Document 19), a method using defatted soybean as an excipient (Patent Document 20), and multi-layered microcapsules (Patent Document 21).
更に、卵黄、卵白を用いた油脂の粉末化技術として、卵白を賦形剤として用いる方法(特許文献22,23)、および、卵黄を用いる方法(特許文献24)などが公知である。卵黄乾燥品には通常25wt%前後の脂質が含まれており、リン脂質の含有量は28wt%前後とされている(非特許文献6)が、このものの高度不飽和脂肪酸エステル(特に、ω3系高度不飽和脂肪酸エチルエステル)に対する抗酸化作用を利用した粉末は知られていない。 Further, as a technique for powdering fats and oils using egg yolk and egg white, a method using egg white as an excipient (Patent Documents 22 and 23) and a method using egg yolk (Patent Document 24) are known. Dried egg yolk usually contains about 25 wt% lipid, and the content of phospholipid is about 28 wt% (Non-Patent Document 6), but the highly unsaturated fatty acid ester of this product (particularly, ω3 type) There are no known powders that utilize the antioxidant activity against highly unsaturated fatty acid ethyl esters.
上記の背景技術の存在にも関わらず、製品化の過程および製品の保存期間中における酸化の進行を官能評価的に異臭発現が気にならないレベル以内に保持する技術は未だ開発されていない。それゆえ、本発明は、製品化の過程および製品の保存期間中における酸化の進行を妨げるおよび/または遅らせることを課題とする。より具体的には、以下のとおりである:
ALA、SDA、EPA、DPA、DHA等のω3系高度不飽和脂肪酸のエチルエステルは酸化速度が大きく、高純度に精製されるほどその速度は大きくなるため、少なくとも10wt%以上の該ω3系高度不飽和脂肪酸のエチルエステルを含む混合物を酸化から保護することは従来技術では十分に成されて来なかったため依然として未解決の技術的課題である。また、酸化に伴う各種の分解物、特に、魚臭を伴う不快な酸化臭の発現は未解決の技術的課題である。従って、該エチルエステルの酸化進行を遮断し、魚臭の発現を阻止することが重要であるが、不飽和結合を3個以上有する高度不飽和脂肪酸の物性上の特徴に鑑みて完全な酸化進行防止、魚臭発現阻止は非現実的との観点から、本発明では、製品化の過程および製品の保存期間中における酸化の進行が官能評価的に異臭発現が気にならないレベル以内に保持されることを技術的課題としている。
Despite the existence of the above-mentioned background technology, a technology for keeping the progress of oxidation in the process of commercialization and the progress of oxidation during the storage period of the product within the level at which the expression of offensive odor is not noticed by sensory evaluation has not yet been developed. Therefore, it is an object of the present invention to prevent and / or delay the progress of oxidation during the process of commercialization and the shelf life of the product. More specifically:
Ethyl esters of ω3 polyunsaturated fatty acids such as ALA, SDA, EPA, DPA, and DHA have a high oxidation rate, and the higher the purity, the higher the rate. Protecting mixtures containing ethyl esters of saturated fatty acids from oxidation has not been sufficiently accomplished by prior art and remains an unsolved technical challenge. In addition, the development of various decomposition products associated with oxidation, particularly an unpleasant oxidative odor accompanied by a fishy odor, is an unsolved technical problem. Therefore, it is important to block the oxidation progress of the ethyl ester and prevent the development of fishy odor, but the complete oxidation progress in view of the physical characteristics of highly unsaturated fatty acids having three or more unsaturated bonds. From the viewpoint that prevention and prevention of fishy odor development are unrealistic, in the present invention, the progress of oxidation during the process of commercialization and the storage period of the product is maintained within a level in which the development of offensive odor is not noticeable in terms of sensory evaluation. That is a technical issue.
更に、上記技術的課題の解決のために、本発明ではまた、ω3系高度不飽和脂肪酸のエチルエステルの食品分野での用途拡大を容易にするため、抗酸化性に優れた粉末である高度不飽和脂肪酸エチルエステル含有組成物及び該組成物を含有する食品を提供する。 Further, in order to solve the above technical problems, in the present invention, in order to facilitate the expansion of applications of ethyl esters of ω3 polyunsaturated fatty acids in the food field, polyunsaturated fatty acids are powders having excellent antioxidant properties. A composition containing a saturated fatty acid ethyl ester and a food containing the composition are provided.
抗酸化性に優れた粉末である高度不飽和脂肪酸エチルエステル含有組成物及び該組成物を含有する食品の提供により課題の解決を図る。 The problem will be solved by providing a composition containing a highly unsaturated fatty acid ethyl ester, which is a powder having excellent antioxidant properties, and a food containing the composition.
本発明者らは、溶存酸素量が1mg/L以下であって、過酸化物価3以下かつ酸価1以下かつアニシジン価5以下である高度不飽和脂肪酸エステル(例えば、ω3系高度不飽和脂肪酸のエチルエステル)を提供することよって、上記課題を解決した。 The present inventors have a highly unsaturated fatty acid ester having a dissolved oxygen content of 1 mg / L or less, a peroxide value of 3 or less, an acid value of 1 or less, and an anisidin value of 5 or less (for example, ω3 high-unsaturated fatty acids). The above problem was solved by providing ethyl ester).
本発明はまた、例えば、以下を提供する:
(項目1)
高度不飽和脂肪酸または高度不飽和脂肪酸エステルを含む組成物であって、該組成物は、溶存酸素量が1mg/L以下であり、過酸化物価が3以下であり、酸価が1以下であり、かつ、アニシジン価が5以下である、組成物。
(項目2)
さらに、抗酸化剤を含む、項目1に記載の組成物。
(項目3)
さらに、乳化剤を含む、項目1または2に記載の組成物。
(項目4)
前記抗酸化剤が、大豆リン脂質、ビタミンE、およびアスコルビン酸パルミテートからなる群から選択される、項目2に記載の組成物。
(項目5)
前記乳化剤が、卵黄および卵白からなる群から選択される、項目3に記載の組成物。
(項目6)
水分含量が5wt%以下の噴霧乾燥物である、項目1に記載の組成物。
(項目7)
項目1に記載の組成物を含む、食品。
(項目8)
α−リノレン酸、ステアリドン酸、エイコサペンタエン酸、ドコサペンタエン酸、ドコサヘキサエン酸からなる群から選択される高度不飽和脂肪酸のエステルを40wt%〜99wt%含有する、項目1に記載の組成物。
(項目9)
前記組成物中の高度不飽和脂肪酸エステルの総含有量が20wt%〜60wt%である、項目1に記載の組成物。
(項目10)
前記高度不飽和脂肪酸または高度不飽和脂肪酸エステルが、吸着剤処理された高度不飽和脂肪酸または高度不飽和脂肪酸エステルである、項目1に記載の組成物。
(項目11)
項目1に記載の組成物を固形物換算で、5wt%〜50wt%含む食品。
(項目12)
パン類、麺類、菓子類、植物等油脂食品類、大豆たんぱく食品、味噌、乳製品、肉製品、卵製品、魚肉練り製品、および、インスタント食品からなる群から選択される、項目11に記載の食品。
The invention also provides, for example:
(Item 1)
A composition comprising a highly unsaturated fatty acid or a highly unsaturated fatty acid ester, wherein the dissolved oxygen content is 1 mg / L or less, the peroxide value is 3 or less, and the acid value is 1 or less. A composition having an anicidin value of 5 or less.
(Item 2)
The composition according to item 1, further comprising an antioxidant.
(Item 3)
The composition according to item 1 or 2, further comprising an emulsifier.
(Item 4)
The composition according to item 2, wherein the antioxidant is selected from the group consisting of soybean phospholipids, vitamin E, and ascorbic acid palmitate.
(Item 5)
The composition according to item 3, wherein the emulsifier is selected from the group consisting of egg yolk and egg white.
(Item 6)
The composition according to item 1, which is a spray-dried product having a water content of 5 wt% or less.
(Item 7)
A food product comprising the composition according to item 1.
(Item 8)
The composition according to item 1, which contains 40 wt% to 99 wt% of an ester of a highly unsaturated fatty acid selected from the group consisting of α-linolenic acid, stearidonic acid, eicosapentaenoic acid, docosapentaenoic acid, and docosahexaenoic acid.
(Item 9)
The composition according to item 1, wherein the total content of the polyunsaturated fatty acid ester in the composition is 20 wt% to 60 wt%.
(Item 10)
The composition according to item 1, wherein the highly unsaturated fatty acid or highly unsaturated fatty acid ester is an adsorbent-treated highly unsaturated fatty acid or highly unsaturated fatty acid ester.
(Item 11)
A food containing 5 wt% to 50 wt% of the composition according to item 1 in terms of solid matter.
(Item 12)
The food according to item 11, which is selected from the group consisting of breads, noodles, confectionery, oil and fat foods such as plants, soy protein foods, miso, dairy products, meat products, egg products, fish paste products, and instant foods. ..
本発明はまた、例えば、溶存酸素量が1mg/L以下であって、過酸化物価3以下かつ酸価1以下かつアニシジン価5以下である高度不飽和脂肪酸エステル(例えば、ω3系高度不飽和脂肪酸のエチルエステル)と、大豆リン脂質及びビタミンE及びアスコルビン酸パルミテートを含む混合物と卵黄の乳化混合物に、更に、卵白を加えて均質化した組成物を噴霧乾燥法により乾燥し、水分含量を5wt%以下に調整した粉末であることを特徴とするω3系高度不飽和脂肪酸エチルエステル含有組成物並びに該組成物を含有する食品を提供する。 The present invention also provides, for example, a highly unsaturated fatty acid ester having a dissolved oxygen content of 1 mg / L or less, a peroxide value of 3 or less, an acid value of 1 or less, and an anisidin value of 5 or less (for example, ω3 high unsaturated fatty acids). Ethyl ester), a mixture containing soybean phospholipids and vitamin E and ascorbic acid palmitate, and an emulsified mixture of egg yolks, and egg whites were added and homogenized, and the homogenized composition was dried by a spray drying method to reduce the water content to 5 wt%. Provided are a composition containing an ω3 highly unsaturated fatty acid ethyl ester, which is a powder prepared below, and a food containing the composition.
(用語の定義)
以下に本明細書において特に使用される用語の定義を列挙する。
(Definition of terms)
The following is a list of definitions of terms specifically used herein.
本明細書において使用される用語「高度不飽和脂肪酸」とは、炭素数が16以上、かつ分子内に二重結合を2個以上有した不飽和脂肪酸を意味し、代表的には、ドコサヘキサエン酸(DHA)などのオメガ3系脂肪酸のエチルエステルが挙げられる。高度不飽和脂肪酸としては、例えば、ドコサヘキサエン酸(C22:6、DHA)、エイコサペンタエン酸(C20:5、EPA)、アラキドン酸(C20:4、AA)、ドコサペンタエン酸(C22:5、DPA)、ステアリドン酸(C18:4、SDA)、α−リノレン酸(C18:3、ALA)、リノール酸(C18:2)等が挙げられるがこれらに限定されない。本発明の取得方法で得られる高度不飽和脂肪酸の誘導体とは、脂肪酸が遊離型でないものをいい、例えば、高度不飽和脂肪酸のメチルエステル、エチルエステル等のエステル型誘導体、アミド、メチルアミド等のアミド型誘導体、脂肪アルコール型誘導体、トリグリセライド、ジグリセライド、モノグリセライド等が挙げられるがこれらに限定されない。好ましくは、本発明の精製方法の目的物質は、ドコサペンタエン酸、エイコサペンタエン酸、および、ドコサヘキサエン酸、ならびに、それらの低級アルコール(例えば、メタノールおよびエタノール)とのエチルエステルからなる群から選択されるエチルエステルである。好ましくは、本発明の高度不飽和脂肪酸または高度不飽和脂肪酸エステルは、最終精製オイル中で50wt%〜95wt%含まれる。 As used herein, the term "polyunsaturated fatty acid" means an unsaturated fatty acid having 16 or more carbon atoms and having two or more double bonds in the molecule, and is typically docosahexaenoic acid. Ethyl esters of omega-3 fatty acids such as (DHA) can be mentioned. Examples of polyunsaturated fatty acids include docosahexaenoic acid (C22: 6, DHA), eicosapentaenoic acid (C20: 5, EPA), arachidonic acid (C20: 4, AA), and docosapentaenoic acid (C22: 5, DPA). ), Stearidonic acid (C18: 4, SDA), α-linolenic acid (C18: 3, ALA), linoleic acid (C18: 2) and the like, but are not limited thereto. The derivative of the highly unsaturated fatty acid obtained by the acquisition method of the present invention means that the fatty acid is not a free type, for example, an ester type derivative such as a methyl ester or an ethyl ester of a highly unsaturated fatty acid, or an amide such as an amide or a methyl amide. Examples include, but are not limited to, type derivatives, fatty alcohol type derivatives, triglycerides, diglycerides, monoglycerides and the like. Preferably, the target substance of the purification method of the present invention is selected from the group consisting of docosapentaenoic acid, eicosapentaenoic acid, and docosahexaenoic acid, and ethyl esters with their lower alcohols (eg, methanol and ethanol). Ethyl ester. Preferably, the polyunsaturated fatty acid or polyunsaturated fatty acid ester of the present invention is contained in the final purified oil in an amount of 50 wt% to 95 wt%.
本明細書において使用される用語「酸価」とは、脂肪酸に含まれているカルボン酸の指標であり、試料1g中に含まれている遊離脂肪酸を中和するのに要する水酸化カリウムのmg数をいう。酸価の測定法は、2003年版基準油脂分析試験法((社)日本油化学会編纂)に記載されるとおりである。 As used herein, the term "acid value" is an index of carboxylic acid contained in a fatty acid and is a mg of potassium hydroxide required to neutralize the free fatty acid contained in 1 g of the sample. Say a number. The acid value measurement method is as described in the 2003 version of the standard oil and fat analysis test method (edited by the Japan Oil Chemists' Society).
本明細書において使用される用語「過酸化物価」は「酸価」とは直接的には関係しない。過酸化物価とは、「POV」と互換可能に使用され、油脂の自動酸化の初期に生じる一次生成物である過酸化物の量を表す。混合物(原料油脂)に過酸化物が存在する場合、過酸化物は不安定なため、分解しアルデヒドを生成する。アルデヒドは、一般的に毒性があるため、アルデヒドの発生を抑えることも重要である。「過酸化物価(POV)」は、ヨウ化カリウムを試料と反応させ、油脂中のヒドロペルオキシドによってヨウ化カリウムから遊離するヨウ素を滴定することにより測定することができる。より詳細には、2003年版基準油脂分析試験法((社)日本油化学会編纂)に記載されるとおりである。 The term "peroxide value" used herein is not directly related to "acid value". Peroxide value is used interchangeably with "POV" and represents the amount of peroxide, which is the primary product produced in the early stages of autoxidation of fats and oils. When a peroxide is present in the mixture (raw material fat), the peroxide is unstable and decomposes to produce an aldehyde. Since aldehydes are generally toxic, it is also important to control the generation of aldehydes. The "peroxide value (POV)" can be measured by reacting potassium iodide with a sample and titrating the iodine liberated from potassium iodide by hydroperoxide in the fat. More details are as described in the 2003 version of the standard oil and fat analysis test method (edited by the Japan Oil Chemists' Society).
本明細書において使用される用語「抗酸化剤」とは、生体内、食品、日用品、工業原料において酸素が関与する有害な反応を減弱もしくは除去する物質をいう。代表的には、抗酸化剤としては、トコフェロール、アスコルビン酸パルミテート、レシチン、カテキン、および、ローズマリー抽出物、ならびに、ブチルヒドロキシトルエンが挙げられるがこれらに限定されない。 As used herein, the term "antioxidant" refers to a substance that attenuates or eliminates harmful reactions involving oxygen in living organisms, foods, daily necessities, and industrial raw materials. Typically, antioxidants include, but are not limited to, tocopherol, ascorbic acid palmitate, lecithin, catechin, and rosemary extract, and butylhydroxytoluene.
本明細書で用いる脂肪酸組成分析法の測定法は、周知であり、例えば、2003年版基準油脂分析試験法((社)日本油化学会編纂)に記載されるとおりである。 The method for measuring the fatty acid composition analysis method used in the present specification is well known, and is as described in, for example, the 2003 version of the standard oil and fat analysis test method (edited by the Japan Oil Chemists' Society).
本明細書において使用される用語「真空精密蒸留法」とは、各成分の沸点差を利用して分離する方法をいう。例えば、EPAの場合、EPAを含む炭素鎖数が20の成分は魚油脂肪酸の中で中間の沸点に位置しており、バッチ式の場合、単塔式蒸留装置を用いる事が、連続蒸留の場合、二塔式装置ないしは四塔式装置が必要となる。二塔式であればC19以下の成分(初留)を留出させ、その残留分を第二塔に送りC20成分を(主留)を分取することにより精製を行う。 As used herein, the term "vacuum precision distillation method" refers to a method of separation using the difference in boiling points of each component. For example, in the case of EPA, the component having 20 carbon chains including EPA is located at an intermediate boiling point among fish oil fatty acids, and in the case of the batch type, it is possible to use a single-column distillation apparatus in the case of continuous distillation. , A two-tower device or a four-tower device is required. In the case of a two-tower system, the components (initial distillate) of C19 or less are distilled off, the residual amount is sent to the second tower, and the C20 component (main distillate) is separated for purification.
本明細書において使用される用語「固定層クロマトグラフィー法」とは、カラムに充填剤を詰め、原料を溶離液で通過させることにより目的の成分を含む画分を取り出し、濃縮・精製する方法をいう。好ましい充填剤としては、シリカゲル、逆相シリカゲル、硝酸銀含浸シリカゲルが挙げられるがこの限りではない。 The term "fixed layer chromatography method" used in the present specification is a method in which a column is filled with a filler and a raw material is passed through an eluent to take out a fraction containing a target component, and concentrate and purify the fraction. say. Preferred fillers include, but are not limited to, silica gel, reverse phase silica gel, and silver nitrate impregnated silica gel.
本明細書において使用される用語「SMBクロマトグラフィー」とは、液体クロマトグラフィーの原理を利用する分離法であって、原料中の特定の成分と、別の特定の成分に対して異なる選択的吸着能力を有する吸着剤が充填された複数の単位充填層を直列に連結するとともに、最下流部の単位充填層と最上流部の単位充填層とを連結し、無端状の循環系を形成した移動層を用いるクロマトグラフィーをいう。本願明細書において、「SMBクロマトグラフィー」は、「擬似移動層クロマトグラフィー」と互換可能に使用される。 As used herein, the term "SMB chromatography" is a separation method that utilizes the principles of liquid chromatography, with different selective adsorptions of a particular component in a raw material and another particular component. A movement in which a plurality of unit-filled layers filled with a capable adsorbent are connected in series, and a unit-filled layer in the most downstream part and a unit-filled layer in the most upstream part are connected to form an endless circulation system. Chromatography using layers. As used herein, "SMB chromatography" is used interchangeably with "pseudo-moving layer chromatography."
本明細書において使用される用語「ウィンタリング処理」とは、「脱ろう」と互換可能に使用され、油脂を指定した低温に長時間保って融点の高い油脂(例えば、グリセリドまたはアシルグリセロール)を析出される処理をいう。 As used herein, the term "wintering treatment" is used interchangeably with "dewaxing" to keep fats and oils at specified low temperatures for extended periods of time to provide fats and oils with a high melting point (eg, glycerides or acylglycerols). The process of precipitation.
本発明において使用される吸着剤としては、例えば、活性炭、活性白土、酸性白土、ケイ酸(シリカ)、シリカゲル、アルミナ、酸化マグネシウムなどの吸着剤から選ばれる1種類以上の組み合わせが挙げられるがこれらに限定されない。吸着剤処理によって、濃縮精製されたEPAエチルエステルおよびDHAエチルエステルのような不飽和脂肪酸エチルエステルは、精製中に発生した脂質の過酸化物、着色成分、原料由来の異物などの不純物を含むため、周知の手法に基づき活性炭、活性白土、酸性白土、ケイ酸(シリカ)、シリカゲル、アルミナ、酸化マグネシウムなどの吸着剤から選ばれる1種類以上の組み合わせにより吸着剤処理される。例えば、吸着剤処理によって、POVを3以下、望ましくは1以下とすることができる(すなわち、脂質の過酸化物を含む不純物を除去することによって、POVを低下させることができる)。 Examples of the adsorbent used in the present invention include one or more combinations selected from adsorbents such as activated carbon, activated clay, acid clay, silicic acid (silica), silica gel, alumina, and magnesium oxide. Not limited to. Since unsaturated fatty acid ethyl esters such as EPA ethyl ester and DHA ethyl ester that have been concentrated and purified by adsorbent treatment contain impurities such as lipid peroxides, coloring components, and foreign substances derived from raw materials generated during purification. Based on a well-known method, the adsorbent is treated with one or more combinations selected from adsorbents such as activated charcoal, activated clay, acidic clay, silicic acid (silica), silica gel, alumina, and magnesium oxide. For example, the adsorbent treatment can reduce the POV to 3 or less, preferably 1 or less (ie, the POV can be reduced by removing impurities including lipid peroxides).
本明細書において使用される用語「アニシジン価」とは、カルボニル化合物を比色定量する方法をいう。発色にp−アニシジンを用いる。操作がカルボニル価(CV)よりも簡便であるため、フライ油の劣化度評価法として、EU諸国において使用されている。ただし、発色の強度がカルボニル化合物の種類(二重結合の有無や炭素数)によって異なるため、脂肪酸組成が異なる油脂同士を比較することはできない。 As used herein, the term "anisidine valence" refers to a method of colorimetrically quantifying a carbonyl compound. Use p-anisidine for color development. Since the operation is simpler than the carbonyl value (CV), it is used in EU countries as a method for evaluating the degree of deterioration of frying oil. However, since the intensity of color development differs depending on the type of carbonyl compound (presence or absence of double bond and number of carbon atoms), it is not possible to compare fats and oils having different fatty acid compositions.
本明細書において使用される用語「エステル化」とは、脂肪酸を低級アルコール存在下でエステル化する反応をいう。脂肪酸をエステル化する方法は、当該分野で周知である。例えば、酸触媒存在下で低級アルコールを用いて脂肪酸をエステル化する方法は酸触媒法として周知であり、アルカリ触媒存在下で低級アルコールを用いて脂肪酸をエステル化する方法はアルカリ触媒法として周知である(日本油化学会編、第4版油脂化学便覧、丸善(東京)、2001年、454〜456頁; 岡原光男他編、加水分解、エステル化およびエステル交換、改定3版油脂化学便覧(日本油化学会編)、丸善(東京) 388−389(1990))。また、リパーゼのような酵素を用いる脂肪酸のエチルエステル化もまた酵素法として周知である(特開2006−288228号)。本発明においては、必要に応じて2つ以上のエステル化法を組み合わせてもよい。好ましくは、酸触媒法または酵素法によって最初のエステル化を行った後に、アルカリ触媒法によるエステル化を行う。エタノールを利用したエステル化をエチルエステル化という。 As used herein, the term "esterification" refers to the reaction of esterifying a fatty acid in the presence of a lower alcohol. Methods of esterifying fatty acids are well known in the art. For example, a method of esterifying a fatty acid using a lower alcohol in the presence of an acid catalyst is well known as an acid catalyst method, and a method of esterifying a fatty acid using a lower alcohol in the presence of an alkali catalyst is well known as an alkali catalyst method. Yes (edited by the Japan Oil Chemists' Society, 4th Edition Oil and Fat Chemistry Handbook, Maruzen (Tokyo), 2001, pp. 454-456; Mitsuo Okahara et al., Hydrolysis, Esterification and Ester Exchange, Revised 3rd Edition Oil and Fat Chemistry Handbook (Japan) Esterification Society), Maruzen (Tokyo) 388-389 (1990)). Ethyl esterification of fatty acids using an enzyme such as lipase is also well known as an enzymatic method (Japanese Patent Laid-Open No. 2006-288228). In the present invention, two or more esterification methods may be combined, if necessary. Preferably, the first esterification is carried out by an acid-catalyzed method or an enzymatic method, and then the esterification is carried out by an alkali-catalyzed method. Esterification using ethanol is called ethyl esterification.
本明細書において使用される用語「抗酸化剤」とは、酸化を防止および/または抑制する任意の物質をいう。本発明の抗酸化剤は、好ましくは、製造工程中あるいは製品保管中における酸化の進行に伴う魚油に特有の生臭い不快な魚臭様の異臭などの発現を気にならないレベル以内に保持することが可能である。 As used herein, the term "antioxidant" refers to any substance that prevents and / or suppresses oxidation. The antioxidant of the present invention is preferably kept within a level at which the development of fish oil-specific fishy odor, unpleasant fishy odor-like offensive odor, etc., which accompanies the progress of oxidation during the manufacturing process or product storage, is not noticeable. It is possible.
抗酸化剤としてはビタミンEとそのシナージストとして大豆リン脂質及びアスコルビン酸パルミテートが挙げられるがこれらに限定されない。ビタミンEは合成ビタミンE(dl−α−トコフェロール)、天然ビタミンE(d−α−トコフェロール)の他、天然のα−、β−、γ−、δ−トコフェロールの混合品(ミックストコフェロール)も利用可能であるが、経済性、価格に対する抗酸化力の活性比較から勘案して、ミックストコフェロールが最も好ましい。添加量はω3系高度不飽和脂肪酸エチルエステルに対して0.01〜3wt%が望ましいが、経済性を考慮した時、0.05〜1.0wt%が最も望ましい。 Examples of the antioxidant include, but are not limited to, vitamin E and soybean phospholipids and ascorbic acid palmitate as its sinargists. Vitamin E uses synthetic vitamin E (dl-α-tocopherol), natural vitamin E (d-α-tocopherol), and a mixture of natural α-, β-, γ-, and δ-tocopherol (mixed tocopherol). Although it is possible, mixed tocopherols are most preferable in consideration of economic efficiency and comparison of antioxidant activity with respect to price. The addition amount is preferably 0.01 to 3 wt% with respect to the ω3 polyunsaturated fatty acid ethyl ester, but is most preferably 0.05 to 1.0 wt% in consideration of economic efficiency.
大豆リン脂質は通常リン脂質を60wt%程度含有するペースト(液状)製品とリン脂質を95%wt%程度含有する粉末製品が知られている。また、大豆リン脂質を構成する主要な成分であるホスファチジルコリン、ホスファチジルエタノールアミン、ホスファチジルセリン、ホスファチジルイノシトールなどの何れかを濃縮精製した分画製品も知られている。本発明に於いてはペースト(液状)製品、粉末製品とも利用可能である。分画製品の場合はホスファチジルコリン及びホスファチジルエタノールアミンが利用可能である。いずれの場合も、製品の形状に関わらず、リン脂質分としての添加量はω3系高度不飽和脂肪酸エチルエステルに対して0.1〜10wt%が望ましいが、リン脂質添加に伴う官能評価的な品質の低下を考慮した時、1〜8.0wt%が最も望ましい。大豆リン脂質を用いた時、本発明で用いる卵黄に含まれるリン脂質との相乗的な有効性も期待される。 As soybean phospholipids, paste (liquid) products containing about 60 wt% of phospholipids and powder products containing about 95% wt% of phospholipids are generally known. Further, fractionated products obtained by concentrating and purifying any of phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, phosphatidylinositol and the like, which are the main components constituting soybean phospholipids, are also known. In the present invention, both paste (liquid) products and powder products can be used. For fractionated products, phosphatidylcholine and phosphatidylethanolamine are available. In either case, regardless of the shape of the product, the amount added as a phospholipid is preferably 0.1 to 10 wt% with respect to the ω3 polyunsaturated fatty acid ethyl ester, but the sensory evaluation associated with the addition of phospholipids. Considering the deterioration of quality, 1 to 8.0 wt% is the most desirable. When soybean phospholipids are used, synergistic effectiveness with the phospholipids contained in the egg yolk used in the present invention is also expected.
アスコルビン酸パルミテートはビタミンEとの相乗的な抗酸化作用が期待されるため、本発明に於いては、添加量はω3系高度不飽和脂肪酸エチルエステルに対して0.01〜1wt%が望ましいが、油脂に対する溶解度を考慮した時、0.05〜0.1wt%が最も望ましい。 Since ascorbic acid palmitate is expected to have a synergistic antioxidant effect with vitamin E, in the present invention, the addition amount is preferably 0.01 to 1 wt% with respect to the ω3 polyunsaturated fatty acid ethyl ester. Considering the solubility in fats and oils, 0.05 to 0.1 wt% is the most desirable.
本明細書において使用される用語「乳化剤」とは、高度不飽和脂肪酸または高度不飽和脂肪酸エステルを乳化する任意の物質をいう。本発明の乳化剤としては、例えば、卵黄および/または卵白などの鶏卵品が挙げられるがこれらに限定されない。 As used herein, the term "emulsifier" refers to any substance that emulsifies polyunsaturated fatty acids or polyunsaturated fatty acid esters. Examples of the emulsifier of the present invention include, but are not limited to, chicken egg products such as egg yolk and / or egg white.
本発明によって、製品化の過程および製品の保存期間中における酸化の進行を妨げるおよび/または遅らせることが可能となる。例えば、本発明にしたがって、製品化の過程および製品の保存期間中における酸化の進行を官能評価的に異臭発現が気にならないレベル以内に保持する技術が提供される。 The present invention makes it possible to prevent and / or delay the progress of oxidation during the process of commercialization and the shelf life of the product. For example, according to the present invention, there is provided a technique for keeping the progress of oxidation in the process of commercialization and the progress of oxidation during the storage period of a product within a level at which the appearance of offensive odor is not noticed by sensory evaluation.
以下、本発明を説明する。本明細書の全体にわたり、単数形の表現は、特に言及しない限り、その複数形の概念をも含むことが理解されるべきである。また、本明細書において使用される用語は、特に言及しない限り、当該分野で通常用いられる意味で用いられることが理解されるべきである。したがって、他に定義されない限り、本明細書中で使用される全ての専門用語および科学技術用語は、本発明の属する分野の当業者によって一般的に理解されるのと同じ意味を有する。矛盾する場合、本明細書(定義を含めて)が優先する。また、本明細書において「wt%」は、「質量パーセント濃度」と互換可能に使用される。 Hereinafter, the present invention will be described. Throughout the specification, it should be understood that the singular representation also includes its plural concept, unless otherwise noted. It should also be understood that the terms used herein are used in the sense commonly used in the art unless otherwise noted. Accordingly, unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. In case of conflict, this specification (including definitions) takes precedence. Also, in the present specification, "wt%" is used interchangeably with "mass fraction concentration".
(高度不飽和脂肪酸エステルの調製)
本発明の高度不飽和脂肪酸エステルは複数種類脂肪酸エステルの混合物であるため、一般に、真空精密蒸留法、分子蒸留法、クロマト法、尿素付加法、硝酸銀錯体法、低温溶媒分別結晶法などの手法を1種類以上組み合わせて精製し、目的とするω3系脂肪酸を少なくとも95wt%以上含む混合物を取得することが出来る(特許文献8)。当然のことながら、これらの精製法そのものは例示の為であって本発明の目的ではないため、エステル化法、濃縮精製法そのものは限定されない。
(Preparation of polyunsaturated fatty acid ester)
Since the highly unsaturated fatty acid ester of the present invention is a mixture of a plurality of types of fatty acid esters, generally, a method such as a vacuum precision distillation method, a molecular distillation method, a chromatographic method, a urea addition method, a silver nitrate complex method, or a low temperature solvent fractionated crystal method is used. It is possible to obtain a mixture containing at least 95 wt% or more of the target ω3 fatty acid by combining and purifying one or more of them (Patent Document 8). As a matter of course, since these purification methods themselves are for illustration purposes only and not the object of the present invention, the esterification method and the concentration purification method itself are not limited.
一般に、高度不飽和脂肪酸含有量が多くヨウ素価も高いエイ肝油やイカ肝油などの魚油は溶存酸素量は其々1.4mg/L、5.7mg/Lであり、通常の植物油、例えば大豆油の溶存酸素量7.6mg/Lよりも低いとされている(非特許文献4、特許文献9)。これは高度不飽和脂肪酸を多く含む魚油はその酸化に伴う酸素の消費速度が植物油より大きく、空気中からの酸素の溶解速度を上回っているためであると理解される。本発明においては不飽和度の高いω3系高度不飽和脂肪酸エチルエステルを用いるため、大半の溶存酸素は過酸化物、あるいはその分解物として存在していると推定される。 In general, fish oils such as ray liver oil and squid liver oil, which have a high content of highly unsaturated fatty acids and a high iodine value, have a dissolved oxygen content of 1.4 mg / L and 5.7 mg / L, respectively, and are ordinary vegetable oils such as soybean oil. It is said that the amount of dissolved oxygen in the above is lower than 7.6 mg / L (Non-Patent Document 4, Patent Document 9). It is understood that this is because fish oil, which contains a large amount of polyunsaturated fatty acids, consumes oxygen at a higher rate than vegetable oil and exceeds the rate at which oxygen is dissolved from the air. Since the ω3 polyunsaturated fatty acid ethyl ester having a high degree of unsaturation is used in the present invention, it is presumed that most of the dissolved oxygen exists as a peroxide or a decomposition product thereof.
ω3系高度不飽和脂肪酸エチルエステルは未加工の原料油脂の段階からエチルエステル化されるまでの過程で大量の溶存酸素を吸収し、過酸化物やその分解物となって存在しており、後の粉末化工程や保存期間中に魚油に特有の生臭い不快な異臭などの発現の原因となる。従って、溶存酸素を吸収して過酸化物やその分解物となったω3系高度不飽和脂肪酸エチルエステルを活性炭、活性白土、酸性白土、シリカゲル、フロリジルなどの吸着剤による処理(非特許文献5、特許文献11)、分子蒸留などの物理的な処理(特許文献10)、クロマト法による処理(非特許文献5)などで予め除去しておくことが重要であるが、本発明に於いてはその除去方法そのものは制限はないため限定されないが、簡便さ、有効性の高さから見て吸着剤による処理が好ましい。また、吸着剤処理工程は本発明における抗酸化剤混合工程までのいずれの段階に挿入しても良いし、複数回実施してもよい。 The ω3 polyunsaturated fatty acid ethyl ester absorbs a large amount of dissolved oxygen in the process from the stage of raw raw fats and oils to ethyl esterification, and exists as a peroxide or its decomposition product. It causes the development of fish oil-specific fishy odors and unpleasant offensive odors during the powdering process and storage period. Therefore, the ω3 highly unsaturated fatty acid ethyl ester, which has absorbed dissolved oxygen and becomes a peroxide or its decomposition product, is treated with an adsorbent such as activated charcoal, activated clay, acid clay, silica gel, and fluorodil (Non-Patent Document 5, Non-Patent Document 5,). It is important to remove it in advance by a physical treatment such as patent document 11), molecular distillation (patent document 10), a treatment by a chromatographic method (non-patent document 5), etc., but in the present invention, the removal thereof is important. The removal method itself is not limited because it is not limited, but treatment with an adsorbent is preferable from the viewpoint of simplicity and high effectiveness. Further, the adsorbent treatment step may be inserted at any stage up to the antioxidant mixing step in the present invention, or may be carried out a plurality of times.
また、過酸化脂質及びその分解物の検出は、本発明では先述のいずれの方法も利用可能であるが、例えば、シリカゲル60PF254TLCプレート(Merk社、0.25mm厚さ)を用いる薄層クロマトグラフィー(TLC)法(非特許文献5)が精度の高さ、簡便さの観点から好ましい。 Further, for the detection of lipid peroxide and its decomposition products, any of the above-mentioned methods can be used in the present invention, and for example, thin layer chromatography using a silica gel 60PF 254 TLC plate (Merk, 0.25 mm thickness) is used. The imaging (TLC) method (Non-Patent Document 5) is preferable from the viewpoint of high accuracy and simplicity.
(エステル化反応)
不飽和脂肪酸のエステル化反応は周知であり、代表的には、酸触媒下でのエステル化反応、アルカリ触媒下でのエステル化反応、および、酵素存在下でのエステル化反応が挙げられるがこれらに限定されない。
(Esterification reaction)
Esterification reactions of unsaturated fatty acids are well known, and typical examples thereof include an acid-catalyzed esterification reaction, an alkali-catalyzed esterification reaction, and an esterification reaction in the presence of an enzyme. Not limited to.
またエステル化反応は、必要に応じてこれらエステル化反応の2つ以上を組み合わせて行ってもよい。好ましくは、酸触媒法または酵素法によって最初のエステル化を行った後に、アルカリ触媒法によるエステル化を行う。 Further, the esterification reaction may be carried out in combination of two or more of these esterification reactions, if necessary. Preferably, the first esterification is carried out by an acid-catalyzed method or an enzymatic method, and then the esterification is carried out by an alkali-catalyzed method.
本発明の高度不飽和脂肪酸は食品用途を前提としているためエチルエステル体が望ましい。 Since the polyunsaturated fatty acid of the present invention is intended for food use, an ethyl ester form is desirable.
(酸触媒下でのエステル化反応)
酸触媒下での低級アルコールによる不飽和脂肪酸のエステル化反応には、周知の反応条件を利用することができる。代表的には、反応条件は、70〜80℃での5時間程度の撹拌である。
(Esterification reaction under acid catalyst)
Well-known reaction conditions can be used for the esterification reaction of unsaturated fatty acids with lower alcohols under an acid catalyst. Typically, the reaction condition is stirring at 70 to 80 ° C. for about 5 hours.
(アルカリ触媒下でのエステル化反応)
アルカリ触媒下で低級アルコールによる不飽和脂肪酸のエステル化反応には、周知の反応条件を利用することができる。代表的には、反応条件は、70〜80℃での1時間程度の撹拌である。
(Esterification reaction under alkaline catalyst)
Well-known reaction conditions can be used for the esterification reaction of unsaturated fatty acids with lower alcohols under an alkali catalyst. Typically, the reaction condition is stirring at 70 to 80 ° C. for about 1 hour.
(酵素存在下でのエステル化反応)
酵素処理に際しては、反応時間、温度などに制限はない。当業者は、例えば、特開2002−69475号公報、特開2013−5589号公報、および、特開2013−121366号公報などに記載される周知の条件を利用することができる。酵素反応の進行はAV測定により管理できる。出発原料の種類、EPA純度、DHA純度など目標としている製品の品質により反応を停止するべきAVは任意に設定できるが、一般に、30〜130の範囲、望ましくは70〜100の範囲で反応を停止する。
(Esterification reaction in the presence of enzyme)
There are no restrictions on the reaction time, temperature, etc. during the enzyme treatment. Those skilled in the art can utilize well-known conditions described in, for example, JP-A-2002-69475, JP-A-2013-5589, JP-A-2013-121366 and the like. The progress of the enzyme reaction can be controlled by AV measurement. The AV to be stopped can be arbitrarily set depending on the type of starting material, EPA purity, DHA purity, etc., depending on the quality of the target product, but generally, the reaction is stopped in the range of 30 to 130, preferably 70 to 100. do.
(エステル化反応の組み合わせ)
エステル化反応は、必要に応じて任意の2つ以上のエステル化反応を任意の順番で組み合わせて行ってもよい。本願の発明者らは酸価が高い高度不飽和脂肪酸を含む原料(特に、酸価が10以上)に対してアルカリ触媒法によるエステル化を行った場合に、高度不飽和脂肪酸の鹸化が生じ、その後の反応が適切に進まないことを見出した。それゆえ、酸価が高い原料では、好ましくは、酸触媒法または酵素法によって最初のエステル化を行った後に、アルカリ触媒法によるエステル化を行う。
(Combination of esterification reactions)
The esterification reaction may be carried out by combining any two or more esterification reactions in any order, if necessary. When the inventors of the present application perform esterification of a raw material containing a highly unsaturated fatty acid having a high acid value (particularly, an acid value of 10 or more) by an alkali catalytic method, saponification of the highly unsaturated fatty acid occurs. It was found that the subsequent reaction did not proceed properly. Therefore, for raw materials having a high acid value, preferably, the first esterification is carried out by an acid catalyst method or an enzymatic method, and then the esterification is carried out by an alkali catalyst method.
エステル化反応を組み合わせる場合、好ましくは、最初のエステル化反応に用いた低級アルコールを除去する。除去方法としては、例えば、蒸発が挙げられるがこれに限定されない。低級アルコール除去後に得られる油層は、必要に応じて水性溶媒(例えば、水、湯、緩衝液が挙げられるがこれらに限定されない)で洗浄される。この洗浄は必要に応じて(例えば、pHが中性になるまで)繰り返され、その後、次のエステル化反応に供される。 When combined with an esterification reaction, the lower alcohol used in the first esterification reaction is preferably removed. Examples of the removal method include, but are not limited to, evaporation. The oil layer obtained after removal of the lower alcohol is washed with an aqueous solvent (for example, but not limited to water, hot water, and a buffer solution), if necessary. This wash is repeated as needed (eg, until the pH is neutral) and then subjected to the next esterification reaction.
(溶存酸素の測定法)
油脂中の溶存酸素の測定は、周知の手法によって可能である。エチルエステル混合物中の溶存酸素の測定方法において使用する測定器等に関しては何らの制限も無いが、例えば、特許文献8に準じて、溶存酸素量測定装置(蛍光式溶存酸素計FOM−1000、株式会社オートマチックシステムリサーチ製)を用いて測定できる。
(Measurement method of dissolved oxygen)
The measurement of dissolved oxygen in fats and oils is possible by a well-known method. There are no restrictions on the measuring instrument or the like used in the method for measuring dissolved oxygen in the ethyl ester mixture, but for example, according to Patent Document 8, a dissolved oxygen amount measuring device (fluorescent dissolved oxygen meter FOM-1000, stock). It can be measured using the company Automatic System Research).
(溶存酸素の低減法)
溶存酸素を低減することによる保存安定性向上を目指す技術が公知となっている。すなわち、油脂へのハイドロキノン添加による溶存酸素の低減化(非特許文献4)、油脂中の酸素を含む溶存気体を二酸化炭素置換することによる風味改善方法(特許文献8)、窒素ガス置換によるマヨネーズなどの水中油型乳化物中の溶存酸素低減化と品質の劣化防止に関する方法(特許文献9)などが公知であり有効性が明らかとなっている。
(Method for reducing dissolved oxygen)
Techniques aimed at improving storage stability by reducing dissolved oxygen are known. That is, reduction of dissolved oxygen by adding hydroquinone to fats and oils (Non-Patent Document 4), flavor improvement method by substituting oxygen-containing dissolved gas in fats and oils with carbon dioxide (Patent Document 8), mayonnaise by substituting nitrogen gas, etc. A method for reducing dissolved oxygen in an oil-in-water emulsion and preventing deterioration of quality (Patent Document 9) is known and its effectiveness has been clarified.
特許文献8に記載の溶存酸素低減法は、油脂組成物中の溶存気体を油脂組成物中の二酸化炭素以外の気体の溶存量が特定の範囲になるまで二酸化炭素で置換(例えば、8.5mL/分程度でのバブリングによる置換)する方法である。 The dissolved oxygen reduction method described in Patent Document 8 replaces the dissolved gas in the fat and oil composition with carbon dioxide until the dissolved amount of a gas other than carbon dioxide in the fat and oil composition reaches a specific range (for example, 8.5 mL). It is a method of replacement by bubbling at about / minute.
特許文献9に記載の溶存酸素低減法は、対象となる組成物を樹脂製容器に充填するに際し、組成物中の溶存酸素量をある一定の濃度範囲まで減じ、かつ樹脂製容器の酸素透過度を特定値以下とし、さらに樹脂製容器に組成物を充填する際には予め容器内を窒素等の不活性ガスで置換しておくことにより、保存中の酸化による劣化を低減する方法である。 The method for reducing dissolved oxygen described in Patent Document 9 reduces the amount of dissolved oxygen in the composition to a certain concentration range when the target composition is filled in the resin container, and the oxygen permeability of the resin container is reduced. Is a method for reducing deterioration due to oxidation during storage by setting the value to a specific value or less and further replacing the inside of the container with an inert gas such as nitrogen when filling the resin container with the composition.
高度不飽和脂肪酸(例えば、高度不飽和脂肪酸エチルエステル)を含む溶液中の溶存酸素は例えば窒素バブリング法によって低減化可能である。窒素以外に、二酸化炭素、アルゴンなどの不活性ガスによる置換法も達成できるが、本発明に於いては、溶存酸素の低減化方法そのものは制限されない(特許文献7)。 Dissolved oxygen in solutions containing polyunsaturated fatty acids (eg, polyunsaturated fatty acid ethyl esters) can be reduced, for example, by the nitrogen bubbling method. Although a substitution method using an inert gas such as carbon dioxide or argon can be achieved in addition to nitrogen, the method itself for reducing dissolved oxygen is not limited in the present invention (Patent Document 7).
本発明者らは高度不飽和脂肪酸エチルエステル中の溶存酸素が1mg/Lを超える場合に、後の粉末化工程や保存期間中に魚油に特有の生臭い不快な異臭などの発現の原因となることを確認したため、本発明に於いては、ω3系高度不飽和脂肪酸エチルエステル中の溶存酸素を1mg/L以下に制限している。下限は設定していないが、少ない方が高品質であることは言うまでもない。そのため、本発明の高度不飽和脂肪酸または高度不飽和脂肪酸エステルを含む組成物の溶存酸素量は、好ましくは、1mg/L以下、0.8mg/L以下、0.6mg/L以下、0.4mg/L以下、0.2mg/L以下、0.1mg/L以下である。 When the dissolved oxygen in the polyunsaturated fatty acid ethyl ester exceeds 1 mg / L, the present inventors may cause the development of a fishy odor, an unpleasant offensive odor peculiar to fish oil during the subsequent powdering step or storage period. Therefore, in the present invention, the dissolved oxygen in the ω3 polyunsaturated fatty acid ethyl ester is limited to 1 mg / L or less. No lower limit has been set, but it goes without saying that the smaller the number, the higher the quality. Therefore, the dissolved oxygen content of the composition containing the polyunsaturated fatty acid or the polyunsaturated fatty acid ester of the present invention is preferably 1 mg / L or less, 0.8 mg / L or less, 0.6 mg / L or less, 0.4 mg. / L or less, 0.2 mg / L or less, 0.1 mg / L or less.
(過酸化物価の低減法)
過酸化脂質やその分解物の除去によって過酸化物価の低減が可能である。過酸化脂質やその分解物の除去法は多数公知となっている。例えば、分子蒸留法(特許文献10および特開2000−342291号公報)、吸着剤処理法(特許文献2、特許文献11、特許文献12、特許文献13)などが知られており、本発明に於いては何れの方法も利用可能である。実験的にはフロリジル(100/200メッシュ)カラムを用いた過酸化脂質の除去法が知られている(非特許文献5)。
(Method of reducing peroxide value)
The peroxide value can be reduced by removing the lipid peroxide and its decomposition products. Many methods for removing lipid peroxides and their decomposition products are known. For example, a molecular distillation method (Patent Document 10 and Japanese Patent Application Laid-Open No. 2000-342291), an adsorbent treatment method (Patent Document 2, Patent Document 11, Patent Document 12, Patent Document 13) and the like are known, and the present invention relates to this method. Either method can be used. Experimentally, a method for removing lipid peroxide using a Florisil (100/200 mesh) column is known (Non-Patent Document 5).
分子蒸留法は、例えば、遠心式分子蒸留法、又は、流下薄膜式分子蒸留法によって行うことが出来る。例えば、流下薄膜式分子蒸留の場合、特開2000−342291号公報に記載されるように、真空度0.005mmHg、蒸発面温度200℃、流速30g/Lの条件で処理を行い、留分として遊離脂肪酸画分、残分としてグリセリド画分を取得できる。流下薄膜式分子蒸留の場合、分子蒸留操作における真空度、蒸発面温度、および/または、フィード量は、装置の型式、原料油の違いにより当業者が適宜変更することができる。 The molecular distillation method can be carried out by, for example, a centrifugal molecular distillation method or a flow-down thin film type molecular distillation method. For example, in the case of flow-down thin-film molecular distillation, as described in JP-A-2000-342291, treatment is performed under the conditions of a vacuum degree of 0.005 mmHg, an evaporation surface temperature of 200 ° C., and a flow velocity of 30 g / L, and the fraction is used as a fraction. A free fatty acid fraction and a glyceride fraction can be obtained as a residual. In the case of the flow-down thin film type molecular distillation, the degree of vacuum, the evaporation surface temperature, and / or the feed amount in the molecular distillation operation can be appropriately changed by those skilled in the art depending on the type of the apparatus and the raw material oil.
吸着剤処理によって過酸化脂質やその分解物を除去することも可能である。本発明において使用する吸着剤としては、例えば、酸性白土、活性白土、活性炭、ケイ酸、および、アルミナが挙げられるがこれらに限定されない。好ましくは、吸着剤は、活性白土またはシリカゲルである。活性白土は、好ましくは、脱ガスし、窒素置換した活性白土であって、活性白土の添加量は、生成物重量の1〜20wt%である。 It is also possible to remove lipid peroxides and their decomposition products by adsorbent treatment. Examples of the adsorbent used in the present invention include, but are not limited to, acidic clay, activated clay, activated carbon, silicic acid, and alumina. Preferably, the adsorbent is activated clay or silica gel. The activated clay is preferably activated clay that has been degassed and substituted with nitrogen, and the amount of the activated clay added is 1 to 20 wt% by weight of the product.
(酸価の低減法)
該エチルエステル混合物は高度不飽和脂肪酸含有量が多いため、エステル化反応後の各工程を経る過程または保存期間中にエチル基が外れて遊離体となり易い。生成した微量の遊離脂肪酸は酸化速度が大きいため官能評価上の品質の劣化を招くだけでなく、酸価の上昇を伴うため除くことが必要である。酸価低減法としては上記過酸化物の低減方法と同様に、分子蒸留などの物理的手段、吸着剤処理などが有効であるがこれらに限定されない。
(Method of reducing acid value)
Since the ethyl ester mixture has a high content of highly unsaturated fatty acids, the ethyl group is likely to come off and become a free substance during the process of each step after the esterification reaction or during the storage period. It is necessary to remove the trace amount of free fatty acid produced because it not only deteriorates the quality of sensory evaluation due to its high oxidation rate but also increases the acid value. Similar to the above-mentioned peroxide reducing method, the acid value reducing method is effective, but is not limited to, physical means such as molecular distillation, adsorbent treatment and the like.
(アニシジン価の低減法)
アニシジン価は主に油脂加工工程中に精製したアルデヒド性熱変性物に由来するとされ、官能評価上も重要な指標である。アニシジン価低減法としては上記過酸化物、酸価の低減方法と同様に、分子蒸留などの物理的手段、吸着剤処理などが有効であるがこれらに限定されない。
(Method for reducing anicidin value)
The anicidin value is said to be mainly derived from the aldehyde heat-denatured product refined during the fat processing process, and is an important index for sensory evaluation. Similar to the above-mentioned peroxide and acid value reduction methods, physical means such as molecular distillation, adsorbent treatment and the like are effective as the anicidin value reduction method, but the method is not limited thereto.
(過酸化物価、酸価、および、アニシジン価の低減法)
本発明において必要とされる過酸化物価、酸価、および、アニシジン価の低減法は、例えば、単一の方法において同時に実施することも可能である。例えば、脱ガム処理・脱酸処理(小野哲夫・太田静行、題名「食用油脂製造技術」、株式会社ビジネスセンター社(1991)、東京)の単一の方法によって同時に実施することも可能である。
(Method for reducing peroxide value, acid value, and anicidin value)
The methods for reducing peroxide value, acid value, and anicidin value required in the present invention can be carried out simultaneously in, for example, a single method. For example, it is possible to carry out the degumming / deoxidizing treatment (Tetsuo Ono / Shizuyuki Ota, title "Edible oil / fat manufacturing technology", Business Center Co., Ltd. (1991), Tokyo) at the same time. ..
(乳化)
本発明に於いては卵黄および/または卵白のような鶏卵品を乳化剤として使用することができる。卵黄は栄養学的にも優れた食品素材であるだけでなく、優れた乳化特性を有し、約50wt%の水分を含む。本発明に於いては、代表的には、溶存酸素量が1mg/L以下であって、過酸化物価3以下かつ酸価1以下かつアニシジン価5以下であって、かつ、吸着剤処理によって過酸化物を除去したω3系高度不飽和脂肪酸のエチルエステルと、大豆リン脂質及びビタミンE及びアスコルビン酸パルミテートを含む混合物に対し、卵黄を重量換算比で0.1〜10倍量、すなわち、乾燥品換算では0.05〜5倍量混合することが出来るが、製品であるω3系高度不飽和脂肪酸エチルエステル含有組成物中のω3系高度不飽和脂肪酸エチルエステルの割合を最終的に20wt%〜50wt%に調整するためには、目的とするω3系高度不飽和脂肪酸のエチルエステルの純度、共存する他のω3系高度不飽和脂肪酸のエチルエステルの含量、抗酸化剤使用量、卵黄、卵白、賦形剤等の配合量などにより変化するため、都度調整する必要があることは当然である。
(Emulsification)
In the present invention, chicken egg products such as egg yolk and / or egg white can be used as an emulsifier. Egg yolk is not only a nutritionally excellent food material, but also has excellent emulsifying properties and contains about 50 wt% water. In the present invention, typically, the amount of dissolved oxygen is 1 mg / L or less, the fatty acid value is 3 or less, the acid value is 1 or less, the anicidin value is 5 or less, and the fatty acid is excessively treated with an adsorbent. The amount of egg yolk is 0.1 to 10 times the weight of the mixture containing the ethyl ester of the ω3 highly unsaturated fatty acid from which the oxide has been removed and the soybean phospholipid and vitamin E and ascorbic acid palmitate, that is, a dried product. Although it can be mixed in an amount of 0.05 to 5 times in terms of conversion, the ratio of the ω3 highly unsaturated fatty acid ethyl ester in the ω3 highly unsaturated fatty acid ethyl ester-containing composition which is the product is finally 20 wt% to 50 wt. In order to adjust to%, the purity of the ethyl ester of the target ω3 highly unsaturated fatty acid, the content of the ethyl ester of other coexisting ω3 highly unsaturated fatty acids, the amount of antioxidant used, egg yolk, egg white, etc. It is natural that it is necessary to adjust each time because it changes depending on the blending amount of the shaping agent and the like.
この混合物は乳化機、例えば高速ホモジナイザーを用いて乳化混合できる。高速ホモジナイザーの機種の限定は無いが、ポリトロン(株式会社セントラル科学貿易)やヒスコトロン(株式会社マイクロテック・ニチオン)などが利用できる。乳化時間、乳化温度、回転速度などは機種やスケールによっても異なり、また、混合物の組成によっても都度異なるため本発明では制限はないが、実験室スケールでは氷冷下、5000〜30000回転/分で5〜10分間程度の乳化混合が適切である。 This mixture can be emulsified and mixed using an emulsifier, for example a high speed homogenizer. There is no limitation on the model of high-speed homogenizer, but Polytron (Central Scientific Trading Co., Ltd.) and Hiscotron (Microtech Nithion Co., Ltd.) can be used. The emulsification time, emulsification temperature, rotation speed, etc. differ depending on the model and scale, and also differ depending on the composition of the mixture, so there is no limitation in the present invention. Emulsification mixing for about 5 to 10 minutes is appropriate.
本発明に於いては、上記乳化混合物に卵白を加えて高速撹拌処理を行う。卵白はアルブミンを主成分としているため、脂溶性成分と複合体を形成するだけでなく、乾燥工程を経た後に流動性に優れた粉末とするために有用である。卵白は通常10〜13wt%の固形分と87〜90wt%の水分から構成されているが、本発明では卵白の固形分含量を12wt%と仮定した時、ω3系高度不飽和脂肪酸のエチルエステル、大豆リン脂質、ビタミンE、アスコルビン酸パルミテートと卵黄から成る上記乳化混合物に対して重量換算比で1〜20倍量、すなわち、乾燥品換算では0.12〜2.4倍量混合することが出来るが、製品であるω3系高度不飽和脂肪酸エチルエステル含有組成物中のω3系高度不飽和脂肪酸エチルエステルの割合を最終的に20wt%〜50wt%に調整するためには、卵白配合量を都度調整する必要がある。この混合物は高速攪拌機、例えば高速ホモジナイザーを用いて撹拌混合できる。高速ホモジナイザーの機種の限定は無いが、ポリトロン(株式会社セントラル科学貿易)やヒスコトロン(株式会社マイクロテック・ニチオン)などが利用できる。撹拌時間、撹拌温度、回転速度などは機種やスケールによっても異なり、また、混合物の組成によっても都度異なるため本発明では制限はないが、実験室スケールでは氷冷下、5000〜30000回転/分で5〜10分間程度の混合が適切である。 In the present invention, egg white is added to the emulsified mixture and a high-speed stirring process is performed. Since egg white contains albumin as a main component, it is useful not only for forming a complex with a fat-soluble component but also for forming a powder having excellent fluidity after undergoing a drying step. Egg white is usually composed of 10 to 13 wt% solid content and 87 to 90 wt% water, but in the present invention, assuming that the solid content of egg white is 12 wt%, ethyl ester of ω3 polyunsaturated fatty acid, It can be mixed in an amount of 1 to 20 times by weight, that is, 0.12 to 2.4 times in terms of dry product, with respect to the above emulsified mixture consisting of soybean phospholipid, vitamin E, ascorbic acid palmitate and egg yolk. However, in order to finally adjust the ratio of the ω3 polyunsaturated fatty acid ethyl ester in the ω3 polyunsaturated fatty acid ethyl ester-containing composition to 20 wt% to 50 wt%, the egg white blending amount is adjusted each time. There is a need to. This mixture can be stirred and mixed using a high speed stirrer, for example, a high speed homogenizer. There is no limitation on the model of high-speed homogenizer, but Polytron (Central Scientific Trading Co., Ltd.) and Hiscotron (Microtech Nithion Co., Ltd.) can be used. The stirring time, stirring temperature, rotation speed, etc. differ depending on the model and scale, and also differ depending on the composition of the mixture, so there is no limitation in the present invention. Mixing for about 5 to 10 minutes is appropriate.
卵白を混合する上記高速撹拌工程においては、乾燥工程を経た後の最終的な粉末製品の粉末としての流動性、ブロッキング性などの性状改善、酸化安定性の更なる向上を目的として適時、賦形剤を同時に、又は、粉末化工程までに添加混合することが出来る。賦形剤としては例えば、デキストリン、アラビアガム、ゼラチン、寒天、澱粉、ペクチン、カラギーナン、カゼイン、カードラン、アルギン酸類、大豆多糖類、プルラン、セルロース類、キサンタイガム、等々が挙げられるが、本発明では賦形剤の添加の有無は必要な要件ではない。添加量はω3系高度不飽和脂肪酸エチルエステル含有組成物中のω3系高度不飽和脂肪酸エチルエステルの割合を最終的に20wt%〜50wt%に調整するためには、賦形剤を重量換算比で都度調整する必要がある。 In the above-mentioned high-speed stirring step of mixing egg whites, timely shaping is performed for the purpose of improving the fluidity of the final powdered product as a powder after the drying step, improving the properties such as blocking property, and further improving the oxidative stability. The agents can be added and mixed at the same time or by the powdering step. Examples of the excipient include dextrin, arabic gum, gelatin, agar, starch, pectin, carrageenan, casein, curdlan, alginic acid, soybean polysaccharide, pullulan, cellulose, xanthy gum, etc., but in the present invention, there are examples. The presence or absence of excipients is not a necessary requirement. The amount of the excipient added is the weight conversion ratio of the excipient in order to finally adjust the ratio of the ω3 polyunsaturated fatty acid ethyl ester in the composition containing the ω3 polyunsaturated fatty acid ethyl ester to 20 wt% to 50 wt%. It needs to be adjusted each time.
新たな溶存酸素の混入防止や混合工程中における空気の混入を防止するため、卵黄、卵白を混合する上記高速撹拌工程は、当然のことながら窒素ガス、アルゴン、二酸化炭素などの不活性ガス環境下で操作されることが望ましい。 In order to prevent the mixing of new dissolved oxygen and the mixing of air during the mixing process, the high-speed stirring step of mixing egg yolk and egg white is, of course, under the environment of an inert gas such as nitrogen gas, argon or carbon dioxide. It is desirable to operate with.
以上の工程で取得されたω3系高度不飽和脂肪酸エチルエステルと抗酸化剤と卵黄と卵白と賦形剤の混合乳化物は、乾燥工程を経て水分含量6wt%以下の粉末体であるω3系高度不飽和脂肪酸エチルエステル含有組成物とする。本発明に於いては製品中の水分量の下限は定義していないが、通常は2wt%以上と見込まれる。乾燥方法としては、噴霧乾燥法、凍結乾燥法を用いることが出来るが、本発明に於いては噴霧乾燥法が望ましい。本発明に於いては、噴霧乾燥法はマイクロカプセル化技術として位置づけている(竹中秀雄、題名「マイクロカプセル化法としての噴霧乾燥法の最近の進歩」、岐阜薬科大学紀要32、1−14(1983−06−03))。すなわち、芯物質は主にω3系高度不飽和脂肪酸エチルエステルと抗酸化剤、壁物質は主に卵白のような乳化剤および賦形剤から構成される。卵黄成分中の脂溶性物質は主に芯物質側に、水溶性物質は壁物質側に分布するが、乳化剤としての特性からカプセル構造の維持にも関与している。 The mixed emulsion of ω3 polyunsaturated fatty acid ethyl ester, antioxidant, egg yolk, egg white and excipient obtained in the above steps is a powdered body with a water content of 6 wt% or less after the drying step. The composition contains an unsaturated fatty acid ethyl ester. In the present invention, the lower limit of the water content in the product is not defined, but it is usually expected to be 2 wt% or more. As a drying method, a spray drying method or a freeze drying method can be used, but in the present invention, the spray drying method is preferable. In the present invention, the spray drying method is positioned as a microencapsulation technique (Hideo Takenaka, entitled "Recent Advances in Spray Drying Method as a Microencapsulation Method", Gifu Pharmaceutical University Bulletin 32, 1-14 ( 1983-06-03)). That is, the core material is mainly composed of ω3 polyunsaturated fatty acid ethyl ester and antioxidant, and the wall material is mainly composed of emulsifiers and excipients such as egg white. The fat-soluble substances in the egg yolk component are mainly distributed on the core substance side, and the water-soluble substances are distributed on the wall substance side, but they are also involved in the maintenance of the capsule structure due to their properties as emulsifiers.
(粉末化)
本発明の組成物の粉末化には、噴霧乾燥法などの周知の種々の方法を用いることができる。噴霧乾燥法による粉末組成物の製造に際して、噴霧乾燥機の入り口温度、出口温度、送液量などは、原液の物性、混合物の内容、設備操作上の制約等により変動するため、本発明に於いては制限していない。
(Powdered)
Various well-known methods such as a spray drying method can be used for powdering the composition of the present invention. In the production of the powder composition by the spray drying method, the inlet temperature, outlet temperature, liquid feed amount, etc. of the spray dryer vary depending on the physical characteristics of the undiluted solution, the content of the mixture, restrictions on equipment operation, etc., and therefore, in the present invention. There are no restrictions.
以上の工程で調製されたω3系高度不飽和脂肪酸エチルエステル含有組成物はそのまま常温保管しておいても良いし、例えば脱酸素剤存在下にガスバリヤー性の高い包材中に保管しても良いし、冷蔵、冷凍保存しても良いが、例えば6カ月以上の長期間保存が必要な場合には脱酸素剤存在下にガスバリヤー性の高い包材中で冷凍保存する方が良いことは当然である。 The ω3 polyunsaturated fatty acid ethyl ester-containing composition prepared in the above steps may be stored at room temperature as it is, or may be stored in a packaging material having a high gas barrier property in the presence of an oxygen scavenger, for example. It may be stored refrigerated or frozen, but for example, when long-term storage of 6 months or more is required, it is better to store frozen in a packaging material with high gas barrier properties in the presence of an oxygen scavenger. Naturally.
ω3系高度不飽和脂肪酸エチルエステル含有組成物は混合が物理的に許容される全ての食品へ添加可能であるが、一般には、「食料工業」(藤巻正生・三浦洋・大塚謙一・川端俊治・木村進 編、恒星社厚生閣(1985))に記載され定義されているパン類、麺類、菓子類、植物等油脂食品類、大豆たんぱく食品、味噌、乳製品、肉製品、卵製品、魚肉練り製品、インスタント食品への添加が可能である。本発明は前出の「マイクロカプセル化法としての噴霧乾燥法の最近の進歩」に定義されている食品の分類に基づく。 The ω3 highly unsaturated fatty acid ethyl ester-containing composition can be added to all foods that are physically allowed to be mixed, but in general, "food industry" (Masao Fujimaki, Hiroshi Miura, Kenichi Otsuka, Shunji Kawabata)・ Breads, noodles, confectionery, oil and fat foods such as plants, soy protein foods, miso, dairy products, meat products, egg products, fish meat, which are described and defined in Kimura Susumu ed. It can be added to paste products and instant foods. The present invention is based on the food classification defined in "Recent Advances in Spray Drying as a Microencapsulation Method" above.
(食品への応用)
食品への利用に際して、ω3系高度不飽和脂肪酸エチルエステル含有組成物に含まれる卵黄、卵白中のたんぱく質の熱変性を伴う場合、特異的な食感を得ることが出来ることも本発明の特徴である。また、食品への使用に際しては都度マスキングフレーバーの使用が可能であることは言うまでもない。
(Application to food)
It is also a feature of the present invention that a specific texture can be obtained when the protein in egg yolk and egg white contained in the composition containing ω3 polyunsaturated fatty acid ethyl ester is accompanied by heat denaturation when used in foods. be. Needless to say, it is possible to use a masking flavor each time it is used for food.
本発明の組成物は、食品中に1wt%以上、2wt%以上、3wt%以上、4wt%以上、5wt%以上、6wt%以上、7wt%以上、8wt%以上、9wt%以上、10wt%以上、15wt%以上、20wt%以上、30wt%以上含まれる。また本発明の組成物は、食品中に90wt%以下、80wt%以下、70wt%以下、65wt%以下、60wt%以下、55wt%以下、55wt%以下、50wt%以下、40wt%以下、30wt%以下含まれる。例えば、本発明の組成物は、食品中に1wt%〜70wt%、2wt%〜65wt%、3wt%〜60wt%、4wt%〜55wt%、5wt%〜50wt%、7wt%〜40wt%、または、10wt%〜30wt%含まれる。 The composition of the present invention contains 1 wt% or more, 2 wt% or more, 3 wt% or more, 4 wt% or more, 5 wt% or more, 6 wt% or more, 7 wt% or more, 8 wt% or more, 9 wt% or more, 10 wt% or more, in food. It contains 15 wt% or more, 20 wt% or more, and 30 wt% or more. Further, the composition of the present invention is 90 wt% or less, 80 wt% or less, 70 wt% or less, 65 wt% or less, 60 wt% or less, 55 wt% or less, 55 wt% or less, 50 wt% or less, 40 wt% or less, 30 wt% or less in food. included. For example, the composition of the present invention is 1 wt% to 70 wt%, 2 wt% to 65 wt%, 3 wt% to 60 wt%, 4 wt% to 55 wt%, 5 wt% to 50 wt%, 7 wt% to 40 wt%, or It contains 10 wt% to 30 wt%.
本発明の食品は特に限定されることはないが、例えば、パン類、麺類、菓子類、植物等油脂食品類、大豆たんぱく食品、味噌、乳製品、肉製品、卵製品、魚肉練り製品、および/または、インスタント食品が挙げられるがこれらに限定されない。 The food of the present invention is not particularly limited, but for example, breads, noodles, confectionery, oil and fat foods such as plants, soy protein foods, miso, dairy products, meat products, egg products, fish paste products, and / Alternatively, it includes, but is not limited to, instant foods.
(本発明の高度不飽和脂肪酸または高度不飽和脂肪酸エステル)
本発明の高度不飽和脂肪酸または高度不飽和脂肪酸エステルを含む組成物の過酸化物価は、3以下、2以下、1以下、0.5以下、0.2以下、0.1以下であるが、これらに限定されない。
(Polyunsaturated fatty acid or polyunsaturated fatty acid ester of the present invention)
The peroxide value of the composition containing the highly unsaturated fatty acid or the highly unsaturated fatty acid ester of the present invention is 3 or less, 2 or less, 1 or less, 0.5 or less, 0.2 or less, 0.1 or less. Not limited to these.
本発明の高度不飽和脂肪酸または高度不飽和脂肪酸エステルを含む組成物の酸価は、1以下、0.8以下、0.6以下、0.4以下、0.2以下、0.1以下であるが、これらに限定されない。 The acid value of the composition containing the polyunsaturated fatty acid or the polyunsaturated fatty acid ester of the present invention is 1 or less, 0.8 or less, 0.6 or less, 0.4 or less, 0.2 or less, 0.1 or less. Yes, but not limited to these.
本発明の高度不飽和脂肪酸または高度不飽和脂肪酸エステルを含む組成物のアニシジン価は、5以下、4以下、3以下、2以下、1以下、0.5以下、0.2以下、0.1以下であるが、これらに限定されない。 The composition containing the polyunsaturated fatty acid or the polyunsaturated fatty acid ester of the present invention has anicidin value of 5 or less, 4 or less, 3 or less, 2 or less, 1 or less, 0.5 or less, 0.2 or less, 0.1. The following, but not limited to these.
本発明の高度不飽和脂肪酸または高度不飽和脂肪酸エステルを含む組成物は、代表的には、溶存酸素量が1mg/L以下であって、過酸化物価3以下かつ酸価1以下かつアニシジン価5以下である。好ましくは、本発明の組成物は抗酸化剤および/または乳化剤を含む。好ましくは、本発明の組成物は粉末製品として提供される。 The composition containing the highly unsaturated fatty acid or the highly unsaturated fatty acid ester of the present invention typically has a dissolved oxygen content of 1 mg / L or less, a peroxide value of 3 or less, an acid value of 1 or less, and an anisidin value of 5. It is as follows. Preferably, the composition of the invention comprises an antioxidant and / or an emulsifier. Preferably, the composition of the present invention is provided as a powder product.
以下に、実施例に基づいて本発明を説明するが、以下の実施例は、例示の目的のみに提供される。従って、本発明の範囲は、上記発明の詳細な説明にも下記実施例にも限定されるものではなく、請求の範囲によってのみ限定される。 Hereinafter, the present invention will be described based on examples, but the following examples are provided for purposes of illustration only. Therefore, the scope of the present invention is not limited to the detailed description of the above invention or the following examples, but is limited only by the claims.
(実施例1:過酸化物の除去と溶存酸素除去)
DHA純度25.5wt%のカツオ原料油(鹿児島県枕崎産)900gに99%エタノール600mL、濃硫酸62.5gを加え、70〜80℃で5時間撹拌した。撹拌後、真空度0.1MPa、蒸発面温度100℃下でエタノールを除去した。その後、油層を約150mLの湯で洗浄し、洗浄湯のpHが2以上になるまで繰り返した。その後、加圧濾過により不純物を除去した。加圧濾過後、アルカリアルコール(事前に水酸化ナトリウム4.5gを60%エタノール180mLに溶解したもの)を加え、70〜80℃で1時間撹拌した。撹拌後、油層を約150mLの湯で洗浄し、洗浄湯のpHが7以下になるまで繰り返した。その後、真空度0.1MPa、蒸発面温度100℃下で溶媒を除去した。その結果、エチルエステル860gを得た。続けて、上記粗脂肪酸エチルエステル800gを遠心式分子蒸留法により、真空度1.5Pa、蒸発面温度180℃で処理し、脂肪酸エチルエステル760gを留分として取得し、脂肪酸の過酸化物の一部や未反応の脂肪酸等を含む不純物画分は分子蒸留残分側に蒸留残分として分離した。上記脂肪酸エチルエステル760gは真空精密蒸留法と高速液体クロマトグラフィーを用いる方法(特許文献4)と銀錯体法(特願2015−111793)を用いて、DHA純度90wt%のエチルエステル混合物110gを取得した。
(Example 1: Removal of peroxide and removal of dissolved oxygen)
To 900 g of bonito raw material oil (produced in Makurazaki, Kagoshima Prefecture) having a DHA purity of 25.5 wt%, 600 mL of 99% ethanol and 62.5 g of concentrated sulfuric acid were added, and the mixture was stirred at 70 to 80 ° C. for 5 hours. After stirring, ethanol was removed under a vacuum degree of 0.1 MPa and an evaporation surface temperature of 100 ° C. Then, the oil layer was washed with about 150 mL of hot water, and the process was repeated until the pH of the washing hot water became 2 or more. Then, impurities were removed by pressure filtration. After pressure filtration, alkaline alcohol (4.5 g of sodium hydroxide dissolved in 180 mL of 60% ethanol in advance) was added, and the mixture was stirred at 70 to 80 ° C. for 1 hour. After stirring, the oil layer was washed with about 150 mL of hot water and repeated until the pH of the washing water became 7 or less. Then, the solvent was removed under a vacuum degree of 0.1 MPa and an evaporation surface temperature of 100 ° C. As a result, 860 g of ethyl ester was obtained. Subsequently, 800 g of the crude fatty acid ethyl ester was treated by a centrifugal molecular distillation method at a vacuum degree of 1.5 Pa and a evaporation surface temperature of 180 ° C. to obtain 760 g of the fatty acid ethyl ester as a distillate, and one of the fatty acid peroxides. The impurity fraction containing the ester and unreacted fatty acid was separated as a distillation residue on the molecular distillation residue side. For 760 g of the fatty acid ethyl ester, 110 g of an ethyl ester mixture having a DHA purity of 90 wt% was obtained by using a method using vacuum precision distillation, high performance liquid chromatography (Patent Document 4) and a silver complex method (Japanese Patent Application No. 2015-111793). ..
上記エチルエステル混合物100gは過酸化物価(POV)4.4、AV0.1、アニシジン価2.6であって、シリカゲル薄層クロマトグラフィー(TLC)で中性脂質用展開溶媒(n−ヘキサン/ジエチルエーテル/酢酸=85/15/1)を用いて定性的に確認したところ、原点付近に過酸化物の存在が認められた。また、シリカゲル60PF254TLCプレート(Merk社、0.25mm厚さ)を用いる薄層クロマトグラフィー(TLC)法(非特許文献5)で検定した時、過酸化物又はその分解物に相当するスポットが検出された。 100 g of the ethyl ester mixture has a peroxide value (POV) of 4.4, AV0.1 and anicidin value of 2.6, and is a developing solvent for neutral lipids (n-hexane / diethyl) by silica gel thin layer chromatography (TLC). When qualitatively confirmed using ether / acetic acid = 85/15/1), the presence of peroxide was observed near the origin. Further, when tested by a thin layer chromatography (TLC) method (Non-Patent Document 5) using a silica gel 60PF 254 TLC plate (Merk, 0.25 mm thickness), spots corresponding to peroxides or their decomposition products were found. was detected.
エチルエステル混合物95gはフロリジル(100/200mesh)カラムにてn−ヘキサンで溶出させ、過酸化物をフロジリルに吸着除去し、溶出物からヘキサンを窒素ガス気流化で減圧除去した。続けて、シリカゲル(Merk社、シリカゲル60)カラムにて同様に処理し、製品80gを得た。 95 g of the ethyl ester mixture was eluted with n-hexane on a Florisil (100/200 mesh) column, the peroxide was adsorbed and removed on Frosylyl, and hexane was removed from the eluate under reduced pressure by nitrogen gas streaming. Subsequently, the same treatment was performed on a silica gel (Merk, silica gel 60) column to obtain 80 g of a product.
続けて、上記脂肪酸エチルエステル80gを窒素バブリング法(特許文献9、特開2005−110674)により脱酸素処理し、このものに脱気処理済n−ヘキサン0.4L、脱気処理済活性白土4g、脱気処理済シリカゲル2gを添加して室温遮光下にて窒素ガス環境下で30分間撹拌し、脂肪酸エチルエステル画分を含むヘキサン層を濾別した後、n−ヘキサンを真空エバポレーターにて除去し、再度窒素バブリング法に依り残余の微量溶存酸素並びにn−ヘキサンを除去した。 Subsequently, 80 g of the fatty acid ethyl ester was deoxidized by a nitrogen bubbling method (Patent Document 9, Japanese Patent Application Laid-Open No. 2005-110674), and this was degassed with 0.4 L of n-hexane and 4 g of degassed active white clay. , 2 g of degassed silica gel is added, and the mixture is stirred in a nitrogen gas environment at room temperature for 30 minutes to filter out the hexane layer containing the fatty acid ethyl ester fraction, and then n-hexane is removed by a vacuum evaporator. Then, the residual trace amount of dissolved oxygen and n-hexane were removed again by the nitrogen bubbling method.
得られた製品70gの溶存酸素濃度は溶存酸素量測定装置(蛍光式溶存酸素計FDM−1000、株式会社オートマチックシステムリサーチ製)で測定した時0.3mg/Lであって、過酸化物価(POV)0.1、AV0.1、アニシジン価1.0であって、シリカゲル薄層クロマトグラフィー(TLC)で中性脂質用展開溶媒(n−ヘキサン/ジエチルエーテル/酢酸=85/15/1)にて定性的に確認したところ、原点付近に過酸化物の存在が認められなかった。更に、シリカゲル60PF254TLCプレート(Merk社、0.25mm厚さ)を用いる薄層クロマトグラフィー(TLC)法で検定した時、過酸化物およびその分解物に相当するスポットは確認されなかった。また、シリカゲル60PF254TLCプレート(Merk社、0.25mm厚さ)を用いる薄層クロマトグラフィー(TLC)法(非特許文献5)で検定した時、過酸化物又はその分解物に相当するスポットは検出されなかった。 The dissolved oxygen concentration of 70 g of the obtained product was 0.3 mg / L when measured with a dissolved oxygen amount measuring device (fluorescent dissolved oxygen meter FDM-1000, manufactured by Automatic System Research Co., Ltd.), and the peroxide value (POV). ) 0.1, AV0.1, anicidin value 1.0, and used in a developing solvent for neutral lipids (n-hexane / diethyl ether / acetic acid = 85/15/1) by silica gel thin layer chromatography (TLC). As a result of qualitative confirmation, the presence of peroxide was not observed near the origin. Furthermore, when tested by a thin layer chromatography (TLC) method using a silica gel 60PF 254 TLC plate (Merk, 0.25 mm thick), no spots corresponding to peroxides and their decomposition products were confirmed. Further, when tested by a thin layer chromatography (TLC) method (Non-Patent Document 5) using a silica gel 60PF 254 TLC plate (Merk, 0.25 mm thickness), the spot corresponding to the peroxide or its decomposition product is found. Not detected.
(実施例2:抗酸化剤混合と乳化と粉末化)
実施例1の方法で調製したDHA純度90wt%の脂肪酸エチルエステル混合物100gに対し、ミックストコフェロール(商品名:理研Eオイル、理研ビタミン株式会社)0.3g、大豆レシチン(商品名:SLP−ペースト、辻製油株式会社)3.0g、アスコルビン酸パルミテート(商品名:L−アスコルビン酸パルミチン酸エステル、ディー・エス・エム ジャパン株式会社)0.05gを混合し、窒素ガスバブリング下3時間撹拌し溶解させ、抗酸化剤含有脂肪酸エチルエステル混合物を得た。この混合物の溶存酸素濃度は0.3mg/Lであって、過酸化物価(POV)0.1、AV0.1、アニシジン価1.2であって、シリカゲル薄層クロマトグラフィー(TLC)で中性脂質用展開溶媒(n−ヘキサン/ジエチルエーテル/酢酸=85/15/1)にて定性的に確認したところ、原点付近に過酸化物の存在が認められなかった。
(Example 2: Antioxidant mixing, emulsification and powdering)
To 100 g of a fatty acid ethyl ester mixture having a DHA purity of 90 wt% prepared by the method of Example 1, 0.3 g of mixed tocopherol (trade name: RIKEN E Oil, RIKEN Vitamin Co., Ltd.), soybean lecithin (trade name: SLP-paste, Tsuji Oil Co., Ltd.) 3.0 g and ascorbic acid palmitate (trade name: L-ascorbic acid palmitate, DSM Japan Co., Ltd.) 0.05 g are mixed and stirred under nitrogen gas bubbling for 3 hours to dissolve. , Antioxidant-containing fatty acid ethyl ester mixture was obtained. The dissolved oxygen concentration of this mixture is 0.3 mg / L, the peroxide value (POV) is 0.1, AV0.1, the anicidin value is 1.2, and the mixture is neutral by silica gel thin layer chromatography (TLC). When qualitatively confirmed with a developing solvent for lipids (n-hexane / diethyl ether / acetic acid = 85/15/1), the presence of peroxide was not observed near the origin.
上記抗酸化剤含有脂肪酸エチルエステル混合物100gに対し、卵黄(太陽化学株式会社)200gを混合し、容器のヘッドスペース部分は窒素置換しながら氷冷下ポリトロン(株式会社セントラル科学貿易)にて10000rpmで5分間乳化処理した。続けて、卵白(太陽化学株式会社)400gを加えて氷冷下ポリトロンにて10000rpmで5分間均質化処理し、乾燥前のω3系高度不飽和脂肪酸エチルエステル含有組成物を得た。このものの計算上の固形分量は35.7%(250g)と仮定している。 200 g of egg yolk (Taiyo Kagaku Co., Ltd.) is mixed with 100 g of the above antioxidant-containing fatty acid ethyl ester mixture, and the headspace portion of the container is replaced with nitrogen at 10000 rpm under ice-cooling Polytron (Central Kagaku Trading Co., Ltd.). It was emulsified for 5 minutes. Subsequently, 400 g of egg white (Taiyo Kagaku Co., Ltd.) was added and homogenized with a polytron under ice-cooling at 10000 rpm for 5 minutes to obtain an ω3 polyunsaturated fatty acid ethyl ester-containing composition before drying. The calculated solid content of this is assumed to be 35.7% (250 g).
上記混合物200g(固形分71.4g含む)をスプレードライヤー(GB210型、ヤマト科学株式会社)を用いて噴霧乾燥しω3系高度不飽和脂肪酸エチルエステル含有組成物を得た。噴霧乾燥条件は、入口温度180℃、出口温度100℃、送液量3ml/min、噴霧圧力1.2Kg/cm2とした。 200 g of the above mixture (including 71.4 g of solid content) was spray-dried using a spray dryer (GB210 type, Yamato Kagaku Co., Ltd.) to obtain an ω3 polyunsaturated fatty acid ethyl ester-containing composition. The spray drying conditions were an inlet temperature of 180 ° C., an outlet temperature of 100 ° C., a liquid feed rate of 3 ml / min, and a spray pressure of 1.2 kg / cm 2 .
得られたω3系高度不飽和脂肪酸エチルエステル含有組成物は43g(固形分回収率60.2%)であって、水分含量は赤外線水分計で測定した時、3.5%であった。 The obtained composition containing ω3 polyunsaturated fatty acid ethyl ester was 43 g (solid content recovery rate 60.2%), and the water content was 3.5% when measured with an infrared moisture meter.
また、この組成物を5名のパネルにより揮発成分の臭いを官能検査した時、全員が魚油に特有の生臭い異臭は感知せず良好と評価した。さらに、この組成物を摂食した時にも全員が魚油に特有の生臭い異臭は感知せず良好と評価した。このことから、大変品質良好なω3系高度不飽和脂肪酸エチルエステル含有組成物が取得できたことが証明された。 In addition, when the odor of the volatile component was sensory-tested by a panel of 5 people, all of them did not detect the fishy odor peculiar to fish oil and evaluated it as good. Furthermore, even when this composition was ingested, all of them did not detect the fishy odor peculiar to fish oil and evaluated it as good. From this, it was proved that a composition containing ω3 polyunsaturated fatty acid ethyl ester having very good quality could be obtained.
得られたω3系高度不飽和脂肪酸エチルエステル含有組成物は使用するまでの期間、ガスバリヤー性の高いアルミ包材に脱酸素剤と共に入れて、−20℃で保管した。 The obtained ω3 polyunsaturated fatty acid ethyl ester-containing composition was placed in an aluminum packaging material having a high gas barrier property together with an oxygen scavenger and stored at −20 ° C. until use.
上記工程を繰り返して得られたω3系高度不飽和脂肪酸エチルエステル含有組成物100gからクロロホルム−メタノール法で全脂質72gを抽出した。このものに含まれるDHAエチルエステルは59.5wt%であって、POV1.8、アニシジン価0.9であった。AV、溶存酸素、過酸化物などは大豆レシチンなどの抗酸化剤に由来する成分により影響されるため分析は行わなかった。 72 g of total lipid was extracted from 100 g of the ω3 polyunsaturated fatty acid ethyl ester-containing composition obtained by repeating the above steps by the chloroform-methanol method. The DHA ethyl ester contained in this product was 59.5 wt%, had a POV of 1.8, and had an anisidin value of 0.9. AV, dissolved oxygen, peroxides, etc. were not analyzed because they are affected by components derived from antioxidants such as soybean lecithin.
以上の結果から、上記ω3系高度不飽和脂肪酸エチルエステル含有組成物中のDHAエチルエステル含量は42.8wt%となった。 From the above results, the DHA ethyl ester content in the ω3 polyunsaturated fatty acid ethyl ester-containing composition was 42.8 wt%.
(実施例3:賦形剤)
実施例2で得られた乾燥前のω3系高度不飽和脂肪酸エチルエステル含有組成物200gに対して、賦形剤としてデキストリン(商品名:パインフロー、松谷化学工業株式会社)30gと水100mlを加えて、氷冷下ポリトロンにて3000rpmで5分間均質化処理した。このものの計算上の固形分量は30.7%(101g)と仮定している。
(Example 3: Excipient)
To 200 g of the ω3 polyunsaturated fatty acid ethyl ester-containing composition obtained in Example 2 before drying, 30 g of dextrin (trade name: Pineflow, Matsutani Chemical Industry Co., Ltd.) and 100 ml of water were added as excipients. Then, the homogenization treatment was carried out with a polytron under ice-cooling at 3000 rpm for 5 minutes. The calculated solid content of this product is assumed to be 30.7% (101 g).
上記混合物200g(固形分61.4g含む)を実施例2と同一条件にて噴霧乾燥条した。得られたω3系高度不飽和脂肪酸エチルエステル含有組成物は49g(固形分回収率79.8%)であって、水分含量は赤外線水分計で測定した時、3.5%であった。このことから、賦形剤を用いることにより噴霧乾燥に際しての粉末の流動性が改善され、回収率が向上することが確認された。 200 g of the above mixture (including 61.4 g of solid content) was spray-dried under the same conditions as in Example 2. The obtained ω3 polyunsaturated fatty acid ethyl ester-containing composition was 49 g (solid content recovery rate 79.8%), and the water content was 3.5% when measured with an infrared moisture meter. From this, it was confirmed that the use of the excipient improved the fluidity of the powder during spray drying and improved the recovery rate.
また、このものを5名のパネルにより揮発成分の臭いを官能検査した時、全員が魚油に特有の生臭い異臭は感知せず良好と評価した。さらに、このものを摂食した時にも全員が魚油に特有の生臭い異臭は感知せず良好と評価した。このことから、大変品質良好なω3系高度不飽和脂肪酸エチルエステル含有組成物が取得できたことが証明された。得られた上記ω3系高度不飽和脂肪酸エチルエステル含有組成物は使用するまでの期間、ガスバリヤー性の高いアルミ包材に脱酸素剤と共に入れて、−20℃で保管した。 In addition, when the odor of the volatile component was sensory-tested by a panel of 5 people, all of them did not detect the fishy odor peculiar to fish oil and evaluated it as good. Furthermore, even when this food was eaten, all of them did not detect the fishy odor peculiar to fish oil and evaluated it as good. From this, it was proved that a composition containing ω3 polyunsaturated fatty acid ethyl ester having very good quality could be obtained. The obtained composition containing the ω3 polyunsaturated fatty acid ethyl ester was placed in an aluminum packaging material having a high gas barrier property together with an oxygen scavenger and stored at −20 ° C. until use.
上記工程を繰り返して得られたω3系高度不飽和脂肪酸エチルエステル含有組成物100gからクロロホルム−メタノール法で全脂質50gを抽出した。このものに含まれるDHAエチルエステルは61.0wt%であって、POV1.5、アニシジン価0.6であった。AV、溶存酸素、過酸化物などは大豆レシチンなどの抗酸化剤に由来する成分により影響されるため分析は行わなかった。 From 100 g of the ω3 polyunsaturated fatty acid ethyl ester-containing composition obtained by repeating the above steps, 50 g of total lipid was extracted by the chloroform-methanol method. The DHA ethyl ester contained in this product was 61.0 wt%, had a POV of 1.5, and had an anisidin value of 0.6. AV, dissolved oxygen, peroxides, etc. were not analyzed because they are affected by components derived from antioxidants such as soybean lecithin.
以上の結果から、上記ω3系高度不飽和脂肪酸エチルエステル含有組成物中のDHAエチルエステル含量は30.5wt%となった。 From the above results, the DHA ethyl ester content in the ω3 polyunsaturated fatty acid ethyl ester-containing composition was 30.5 wt%.
(実施例4:うどん)
麺類として、うどんへのω3系高度不飽和脂肪酸エチルエステル含有組成物添加試験を行った。うどん麺は引用文献8(柴田茂久著、4−1 生めん類、乾燥めん類、食料工業、藤巻正生他編、pp59−74(1985)、恒星社厚生閣(東京))及び「新版 てがるにできる加工食品」(峰下雄・津久井亜紀夫 編、pp120−121、建帛社(1991)、東京)に準じて試作した。
(Example 4: Udon)
As noodles, a test for adding an ω3 polyunsaturated fatty acid ethyl ester-containing composition to udon was conducted. Udon noodles are cited in Reference 8 (Shigehisa Shibata, 4-1 Raw noodles, dried noodles, food industry, Masao Fujimaki et al., Pp59-74 (1985), Koseisha Koseikaku (Tokyo)) and "New Edition Tegaru Noodles". Prototypes were made according to "Processed foods" (edited by Yu Minoshita and Akio Tsukui, pp120-121, Kenzosha (1991), Tokyo).
原料は小麦中力粉380g、食塩20g、水180mL、打ち粉(適量)とした。すなわち、中力粉380gに180mLの水に溶かした食塩20g、及び、実施例2で調製したω3系高度不飽和脂肪酸エチルエステル含有組成物100g(DHAエチルエステル含量42.8wt%)を加えて混和、圧延、切り出し、煮沸、水洗工程を経てうどんゆで麺を調整した。本実施例に於いては上記うどんの乾物重量は500g、DHAエチルエステル含量は乾物換算で8.6wt%となるように設計したものである。 The raw materials were 380 g of wheat flour, 20 g of salt, 180 mL of water, and flour (appropriate amount). That is, 20 g of salt dissolved in 180 mL of water and 100 g of the ω3 polyunsaturated fatty acid ethyl ester-containing composition (DHA ethyl ester content 42.8 wt%) prepared in Example 2 are added to 380 g of medium-strength flour and mixed. The udon boiled noodles were prepared through rolling, cutting, boiling, and washing with water. In this example, the dry matter weight of the udon noodles is 500 g, and the DHA ethyl ester content is designed to be 8.6 wt% in terms of dry matter.
上記生うどんを市販のうどんの汁に合わせて5名のパネルによって官能検査した。その結果、揮発成分の臭いを官能検査した時、全員が魚油に特有の生臭い異臭は感知せず良好と評価した。さらに、このものを摂食した時にも全員が魚油に特有の生臭い異臭は感知せず良好と評価した。このことから、大変品質良好なω3系高度不飽和脂肪酸エチルエステル含有組成物が取得できたことが証明された。 The raw udon noodles were sensory-tested by a panel of 5 people according to the soup of commercially available udon noodles. As a result, when the odor of the volatile component was sensory-tested, all of them did not detect the fishy odor peculiar to fish oil and evaluated it as good. Furthermore, even when this food was eaten, all of them did not detect the fishy odor peculiar to fish oil and evaluated it as good. From this, it was proved that a composition containing ω3 polyunsaturated fatty acid ethyl ester having very good quality could be obtained.
(実施例5:インスタント味噌汁)
味噌及びインスタント食品へのω3系高度不飽和脂肪酸エチルエステル含有組成物添加試験を行った。即席みそ汁(商品名「あさげ」、株式会社永谷園)1食分のペースト状味噌16.3g(固形分含量40%と仮定)に熱湯160mL、実施例2で調製したω3系高度不飽和脂肪酸エチルエステル含有組成物1g(DHAエチルエステル含量42.8wt%)を加えて混和した。同様に、実施例2で調製したω3系高度不飽和脂肪酸エチルエステル含有組成物2g、3g、4gを加えて混合した試験区も作成し、共に官能検査に供した。
(Example 5: Instant miso soup)
A test for adding an ω3 polyunsaturated fatty acid ethyl ester-containing composition to miso and ready-to-eat foods was carried out. Instant miso soup (trade name "Asage", Nagatanien Co., Ltd.) 1 serving of paste-like miso 16.3 g (assuming a solid content of 40%), 160 mL of boiling water, ω3 polyunsaturated fatty acid ethyl ester prepared in Example 2. 1 g of the contained composition (DHA ethyl ester content 42.8 wt%) was added and mixed. Similarly, a test group in which 2 g, 3 g, and 4 g of the ω3 polyunsaturated fatty acid ethyl ester-containing composition prepared in Example 2 were added and mixed was also prepared, and both were subjected to a sensory test.
本実施例に於いては上記のペースト状味噌の乾物重量はω3系高度不飽和脂肪酸エチルエステル含有組成物1g加えて混和した区では7.52g、2g加えて混和した区では8.52g、3g加えて混和した区では9.52g、4g加えて混和した区では10.52gであり、ω3系高度不飽和脂肪酸エチルエステル含有組成物の添加量は、それぞれ13.3wt%、23.5wt%、31.5wt%、38.0wt%である。従って、本即席味噌汁一杯に含まれるDHAエチルエステルはそれぞれ、5.7wt%、10.0wt%、13.5wt%、16.3wtである。 In this example, the dry matter weight of the above-mentioned paste-like miso is 7.52 g in the group in which 1 g of the ω3 polyunsaturated fatty acid ethyl ester-containing composition is added and mixed, and 8.52 g and 3 g in the group in which 2 g is added and mixed. In addition, it was 9.52 g in the mixed group and 10.52 g in the group in which 4 g was added, and the amount of the ω3 polyunsaturated fatty acid ethyl ester-containing composition added was 13.3 wt% and 23.5 wt%, respectively. It is 31.5 wt% and 38.0 wt%. Therefore, the DHA ethyl ester contained in a cup of this instant miso soup is 5.7 wt%, 10.0 wt%, 13.5 wt%, and 16.3 wt, respectively.
その結果として得られた味噌汁から立ち上る揮発成分の臭いを官能検査した時、ω3系高度不飽和脂肪酸エチルエステル含有組成物1g、2g、3gを加えた試験区に関しては、全ての試験区について全員が魚油に特有の生臭い異臭は感知せず良好と評価した。さらに、このものを摂食した時にも全ての試験区について全員が魚油に特有の生臭い異臭は感知せず良好と評価した。このことから、大変品質良好なω3系高度不飽和脂肪酸エチルエステル含有組成物が取得できたことが証明された。 When the odor of the volatile components rising from the resulting miso juice was sensory-tested, all of the test plots to which the ω3 polyunsaturated fatty acid ethyl ester-containing composition was added, 1 g, 2 g, and 3 g, were found. The fish oil-specific fishy odor was not detected and was evaluated as good. Furthermore, even when this food was eaten, all the test plots did not detect the fishy odor peculiar to fish oil and evaluated it as good. From this, it was proved that a composition containing ω3 polyunsaturated fatty acid ethyl ester having very good quality could be obtained.
さらに、ω3系高度不飽和脂肪酸エチルエステル含有組成物4gを加えた試験区に関しては、全員が魚臭を感知したが、魚油に特有の生臭い不快な異臭は感知せず良好と評価した。さらに、このものを摂食した時にも全員が魚臭を感知したが、魚油に特有の生臭い異臭は感知せず良好と評価した。このことから、味噌及び即席(インスタント)味噌汁に対して大変品質良好なω3系高度不飽和脂肪酸エチルエステル含有組成物が取得できたことが証明された。 Furthermore, in the test group to which 4 g of the ω3 polyunsaturated fatty acid ethyl ester-containing composition was added, all of them sensed a fishy odor, but did not detect a fishy and unpleasant offensive odor peculiar to fish oil, and evaluated it as good. Furthermore, all of them sensed the fishy odor when they ate this food, but they did not detect the fishy odor peculiar to fish oil and evaluated it as good. From this, it was proved that a composition containing ω3 polyunsaturated fatty acid ethyl ester having very good quality for miso and instant miso soup could be obtained.
また、味噌汁は本来カツオだし、イリコだしなどの魚介系風味と相性が良いことから、ω3系高度不飽和脂肪酸エチルエステル含有組成物を加えた全ての試験区に関して、全員がブランク(ω3系高度不飽和脂肪酸エチルエステル含有組成物無添加の味噌汁)よりもコクがあっておいしいと評価したことは本発明の特記すべき効果である。 In addition, since miso soup is originally compatible with seafood-based flavors such as bonito and irico-dashi, all of the test plots to which the ω3 polyunsaturated fatty acid ethyl ester-containing composition was added were blank (ω3 polyunsaturated fatty acid). It is a remarkable effect of the present invention that it is evaluated to be richer and tastier than the miso soup containing no saturated fatty acid ethyl ester-containing composition.
本発明によって、製品化の過程および製品の保存期間中における高度不飽和脂肪酸または高度不飽和脂肪酸エステルの酸化の進行を妨げるおよび/または遅らせることが可能となる。本発明によって、製品化の過程および製品の保存期間中における酸化の進行を官能評価的に異臭発現が気にならないレベル以内に保持する技術が提供される。 The present invention makes it possible to prevent and / or delay the progress of oxidation of polyunsaturated fatty acids or polyunsaturated fatty acid esters during the process of commercialization and the shelf life of the product. INDUSTRIAL APPLICABILITY The present invention provides a technique for keeping the progress of oxidation in the process of commercialization and the progress of oxidation during the storage period of the product within a level at which the appearance of offensive odor is not noticed by sensory evaluation.
Claims (8)
ここで、該高度不飽和脂肪酸は、ドコサヘキサエン酸(C22:6、DHA)、エイコサペンタエン酸(C20:5、EPA)、アラキドン酸(C20:4、AA)、ドコサペンタエン酸(C22:5、DPA)、ステアリドン酸(C18:4、SDA)、α−リノレン酸(C18:3、ALA)、および、リノール酸(C18:2)からなる群から選択され、
該組成物は、溶存酸素量が1mg/L以下であり、過酸化物価が3以下であり、酸価が1以下であり、かつ、アニシジン価が5以下である、組成物。 A composition containing 10 wt% or more of ethyl ester of polyunsaturated fatty acid.
Here, the polyunsaturated fatty acids are docosahexaenoic acid (C22: 6, DHA), eicosapentaenoic acid (C20: 5, EPA), arachidonic acid (C20: 4, AA), docosapentaenoic acid (C22: 5,). DPA), stearidonic acid (C18: 4, SDA), α-linolenic acid (C18: 3, ALA), and linoleic acid (C18: 2) selected from the group.
The composition has a dissolved oxygen content of 1 mg / L or less, a peroxide value of 3 or less, an acid value of 1 or less, and an anisidin value of 5 or less.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015248498A JP6967334B2 (en) | 2015-12-21 | 2015-12-21 | Compositions Containing Polyunsaturated Fatty Acid Esters |
JP2021100180A JP7129723B2 (en) | 2015-12-21 | 2021-06-16 | Composition containing triglycerides of polyunsaturated fatty acids |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015248498A JP6967334B2 (en) | 2015-12-21 | 2015-12-21 | Compositions Containing Polyunsaturated Fatty Acid Esters |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021100180A Division JP7129723B2 (en) | 2015-12-21 | 2021-06-16 | Composition containing triglycerides of polyunsaturated fatty acids |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2017114776A JP2017114776A (en) | 2017-06-29 |
JP6967334B2 true JP6967334B2 (en) | 2021-11-17 |
Family
ID=59233467
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015248498A Active JP6967334B2 (en) | 2015-12-21 | 2015-12-21 | Compositions Containing Polyunsaturated Fatty Acid Esters |
JP2021100180A Active JP7129723B2 (en) | 2015-12-21 | 2021-06-16 | Composition containing triglycerides of polyunsaturated fatty acids |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021100180A Active JP7129723B2 (en) | 2015-12-21 | 2021-06-16 | Composition containing triglycerides of polyunsaturated fatty acids |
Country Status (1)
Country | Link |
---|---|
JP (2) | JP6967334B2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2019065624A (en) * | 2017-10-03 | 2019-04-25 | 株式会社東海理化電機製作所 | Electronic key system |
JP7353101B2 (en) * | 2019-08-21 | 2023-09-29 | アサヒグループ食品株式会社 | Nutritional supplement composition and method for producing the same, method for suppressing unpleasant odor of animal extract or nutritional supplement composition, and composition for suppressing unpleasant odor of animal extract or nutritional supplement composition |
CN115478083B (en) * | 2021-06-15 | 2024-06-11 | 嘉必优生物技术(武汉)股份有限公司 | Method for preparing phospholipid type polyunsaturated fatty acid by solvent-free system |
JP7521848B2 (en) | 2022-12-23 | 2024-07-24 | 植田製油株式会社 | Oil and fat composition containing highly unsaturated fatty acids |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06172782A (en) * | 1992-12-10 | 1994-06-21 | Ikeda Shiyokuken Kk | Powder of fat and oil containing highly unsaturated fatty acid |
JPH07188692A (en) * | 1993-12-27 | 1995-07-25 | Ikeda Shiyokuken Kk | Removal of peroxide from composition containing highly unsaturated fatty acid |
CA2260397A1 (en) | 1999-01-29 | 2000-07-29 | Atlantis Marine Inc. | Method of converting rendered triglyceride oil from marine sources into bland, stable food oil |
ES2563649T3 (en) * | 2003-12-30 | 2016-03-15 | Dsm Ip Assets B.V. | Deaeration Process |
JP2011205997A (en) * | 2010-03-30 | 2011-10-20 | Fuji Oil Co Ltd | Method for producing oil-in-water emulsified product |
CL2010001587A1 (en) | 2010-12-27 | 2013-01-11 | Golden Omega S A | Process for preparing a concentrate of omega-3 fatty acid ethyl esters comprising over 80% by weight of said esters in cis configuration and their double bonds separated by a methylene unit. |
EP3029021A1 (en) | 2013-07-31 | 2016-06-08 | Bizen Chemical Co., Ltd. | Method for separating fat-soluble material by simulated moving bed chromatography, and device for same |
US20160361285A1 (en) * | 2014-02-28 | 2016-12-15 | Bizen Chemical Co., Ltd. | Method for purifying stearidonic acid |
-
2015
- 2015-12-21 JP JP2015248498A patent/JP6967334B2/en active Active
-
2021
- 2021-06-16 JP JP2021100180A patent/JP7129723B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP7129723B2 (en) | 2022-09-02 |
JP2021137035A (en) | 2021-09-16 |
JP2017114776A (en) | 2017-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7129723B2 (en) | Composition containing triglycerides of polyunsaturated fatty acids | |
TWI572290B (en) | Grease composition | |
RU2533015C2 (en) | Oil compositions of stearidonic acid | |
JP5550147B2 (en) | Deodorization and stabilization of marine oil | |
JP3997043B2 (en) | Oil composition and processed oil product | |
JP5850866B2 (en) | Processing method of cooking oil | |
US20240130993A1 (en) | DHA Enriched Polyunsaturated Fatty Acid Compositions | |
JP2024003139A (en) | Dha-rich polyunsaturated fatty acid compositions | |
JP5710865B2 (en) | How to recycle old cooking oil | |
Rasor et al. | Fats and oils–plant based | |
TWI774898B (en) | Vegetable-based lipid composition, paint or varnish comprising the same, and process for producing the same | |
JP2004018678A (en) | Sterol fatty acid ester composition and foodstuff containing the same | |
TWI706727B (en) | Vegetable-based lipid composition, nutraceutical composition comprising the same, food product comprising the same, and process for producing the same | |
Shahidi et al. | Marine lipids as affected by processing and their quality preservation by natural antioxidants | |
JP2005105248A (en) | Oil and fat composition, food using the composition and process for refining oil and fat | |
Hernandez | Processing of omega-3 oils | |
JP6903846B2 (en) | Composition | |
JP2023107827A (en) | Method for producing marine product-derived free monounsaturated fatty acid or lower alcohol ester thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20181108 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20191112 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200109 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200610 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20200806 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20201008 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20210317 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210616 |
|
C60 | Trial request (containing other claim documents, opposition documents) |
Free format text: JAPANESE INTERMEDIATE CODE: C60 Effective date: 20210616 |
|
C11 | Written invitation by the commissioner to file amendments |
Free format text: JAPANESE INTERMEDIATE CODE: C11 Effective date: 20210629 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20210803 |
|
C21 | Notice of transfer of a case for reconsideration by examiners before appeal proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C21 Effective date: 20210804 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20211008 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20211025 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6967334 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |